drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Amiodarone	Acenocoumarol	0.34	-2.577	None	2236 (675/1561)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#B1CFE5	256.88511858534	0
Omeprazole	Diazepam	0.272	1.76	Moderate	32840 (21749/11091)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F8BABA	3772.85657170955	1
Omeprazole	Alprazolam	0.279	2.145	Moderate	25350 (17873/7477)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F7B9B9	2912.36035605472	1
Haloperidol	Biperiden	0.493	-1.455	Moderate	415 (180/235)		#B4D1E6	47.6776941918229	0
Digoxin	Furosemide	0.363	-1.591	Moderate	1835 (756/1079)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#B2D0E5	210.815828534928	0
Digoxin	Spironolactone	0.382	-1.66	Minor	702 (282/420)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#B2D0E5	80.6499790907462	0
Alendronic acid	Ibuprofen	0.162	17.95	Moderate	8717 (8302/415)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#E38D8D	1001.46135004848	1
Indomethacin	Methotrexate	0.309	1.359	Major	772 (465/307)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F9BCBC	88.6919997978006	0
Mesalazine	Azathioprine	0.379	-1.453	Moderate	311 (135/176)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B4D1E6	35.729549141342	0
Acetylsalicylic acid	Insulin aspart	0.314	-2.081	Moderate	3246 (1132/2114)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#B2D0E5	372.919988787125	0
Omeprazole	Clonazepam	0.257	1.572	Moderate	6201 (3948/2253)		#F8BABA	712.408148634924	1
Trimethoprim	Leucovorin	0.53	-2.051	Major	517 (182/335)		#B2D0E5	59.3960672221022	0
Acetylsalicylic acid	Ibuprofen	0.134	-1.646	Major	17842 (7204/10638)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#B2D0E5	2049.79619221808	1
Acetylsalicylic acid	Gliclazide	0.363	-3.002	None	6046 (1637/4409)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	694.600817069304	0
Omeprazole	Methotrexate	0.304	1.52	Major	3569 (2244/1325)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F9BCBC	410.028170049677	2.89810864816066e-53
Acetylsalicylic acid	Glyburide	0.354	-2.51	Moderate	3529 (1085/2444)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#B1CFE5	405.432729645646	9.92806608663113e-281
Acetaminophen	Acenocoumarol	0.218	-1.587	None	6542 (2699/3843)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	751.58427807929	1
Warfarin	Amiodarone	0.304	-2.022	Major	242 (86/156)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#B2D0E5	27.8024144443883	1.02792694387141e-191
Methotrexate	Hydroxychloroquine	0.31	2.776	Minor	217 (164/53)		#F7B7B7	24.9302641918688	3.72269488610442e-162
Pravastatin	Fenofibrate	0.794	-2.169	Major	1364 (463/901)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#B1CFE5	156.704517777461	0
Digoxin	Amiodarone	0.317	-2.475	Major	380 (118/262)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#B1CFE5	43.6566838382956	1.67923344420008e-246
Atenolol	Ibuprofen	0.15	1.237	Moderate	5767 (3342/2425)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#F9BCBC	662.547620251187	1
Digoxin	Carvedilol	0.335	-3.643	Moderate	683 (160/523)	Digoxin may increase the bradycardic activities of Carvedilol.	#AECDE3	78.4671448988314	0
Carbamazepine	Levetiracetam	0.483	-1.171	Moderate	203 (99/104)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#B4D1E6	23.3218600504579	1.98589568166198e-147
Diclofenac	Alendronic acid	0.14	14.136	Moderate	2999 (2820/179)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#E89898	344.543144292233	1
Acetylsalicylic acid	Insulin detemir	0.308	-1.88	Moderate	1306 (486/820)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#B2D0E5	150.041129191616	3.45458959333665e-170
Digoxin	Verapamil	0.413	-1.018	Moderate	199 (104/95)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#B4D1E6	22.8623160100548	1.84369776835598e-118
Bisoprolol	Ibuprofen	0.129	-1.146	Moderate	6923 (3413/3510)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	795.355847927686	1
Rivastigmine	Quetiapine	0.273	-1.244	Moderate	127 (60/67)		#B4D1E6	14.5905232827988	1.12409039959495e-126
Propafenone	Acenocoumarol	0.329	-1.212	None	215 (103/112)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#B4D1E6	24.7004921716673	1.3678464756768e-116
Warfarin	Propafenone	0.228	1.037	Moderate	69 (37/32)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#F9BCBC	7.92713469695368	3.64283793394922e-61
Omeprazole	Ketazolam	0.264	2.309	None	1665 (1199/466)		#F7B9B9	191.285206817795	1
Alendronic acid	Naproxen	0.155	16.629	Moderate	2383 (2261/122)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#E69191	273.773362070154	1
Tramadol	Citalopram	0.213	3.329	Major	2449 (1929/520)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F6B6B6	281.355838736805	1
Entacapone	Apomorphine	0.2	-2.229	Moderate	6 (2/4)		#B1CFE5	0.689316060604668	3.25417760409705e-12
Tramadol	Fluoxetine	0.216	5.604	Major	1826 (1574/252)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#F3AFAF	209.781854444021	1
Simvastatin	Clarithromycin	0.074	1.486	Major	3421 (2133/1288)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#F9BCBC	393.025040554762	1
Donepezil	Quetiapine	0.294	1.151	Moderate	105 (59/46)		#F9BCBC	12.0630310605817	5.97952606098952e-85
Galantamine	Risperidone	0.338	-1.068	Moderate	47 (24/23)		#B4D1E6	5.39964247473657	9.60360241449095e-48
Torasemide	Ibuprofen	0.163	1.869	Moderate	2522 (1704/818)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F8BABA	289.742517474162	1
Amitriptyline	Duloxetine	0.337	5.978	Major	636 (553/83)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#F3AFAF	73.0675024240948	2.69312675681318e-33
Tramadol	Paroxetine	0.186	4.014	Major	1998 (1633/365)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#F5B4B4	229.542248181354	1
Fenofibrate	Atorvastatin	0.45	-3.461	Major	2143 (522/1621)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#AECDE3	246.200719645967	8.43028872655736e-55
Diltiazem	Atorvastatin	0.48	-2.843	Moderate	1417 (399/1018)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#AFCEE4	162.793476312802	3.59985203644199e-96
Propranolol	Rizatriptan	0.277	3.098	Moderate	187 (145/42)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#F7B7B7	21.4836838888455	1.34602080588398e-64
Prednisone	Acetylsalicylic acid	0.167	-2.162	Moderate	4198 (1428/2770)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#B1CFE5	482.291470403066	1
Levothyroxine	Acenocoumarol	0.279	1.93	None	983 (671/312)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	112.932947929065	1
Digoxin	Propafenone	0.372	1.169	Moderate	76 (43/33)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#F9BCBC	8.73133676765913	1.66662811232808e-45
Furosemide	Ibuprofen	0.22	1.181	Moderate	3197 (1817/1380)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F9BCBC	367.290574292187	1
Risperidone	Donepezil	0.35	-1.148	Moderate	67 (33/34)		#B4D1E6	7.69736267675213	4.44384812115067e-54
Repaglinide	Gliclazide	0.233	-1.666	None	479 (192/287)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	55.0303988382727	1.38689640150022e-31
Amitriptyline	Fluoxetine	0.321	6.364	Major	696 (610/86)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#F2AEAE	79.9606630301415	1
Bisoprolol	Gliclazide	0.332	-2.97	None	1781 (486/1295)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	204.611983989486	1
Levothyroxine	Raloxifene	0.292	73.777	Moderate	749 (740/9)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	86.0496215654827	1
Lamotrigine	Carbamazepine	0.541	-1.095	Moderate	115 (58/57)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#B4D1E6	13.2118911615895	2.59210828575574e-72
Omeprazole	Itraconazole	0.148	1.508	Moderate	1748 (1096/652)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F9BCBC	200.82074565616	1
Galantamine	Quetiapine	0.329	-1.157	Moderate	53 (26/27)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#B4D1E6	6.08895853534123	4.52969709061599e-46
Allopurinol	Acenocoumarol	0.318	-7.469	None	1525 (198/1327)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#A3C5DF	175.201165403686	5.2429659958838e-117
Atenolol	Gliclazide	0.324	-1.693	None	1053 (418/635)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	120.974968636119	1
Diltiazem	Simvastatin	0.427	-1.832	Major	1610 (609/1001)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#B2D0E5	184.966476262253	1
Valproic acid	Carbamazepine	0.511	-1.216	Moderate	138 (66/72)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#B4D1E6	15.8542693939074	4.75033662687533e-68
Methotrexate	Naproxen	0.241	1.607	Major	762 (489/273)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F8BABA	87.5431396967928	1
Propranolol	Ibuprofen	0.174	1.795	Moderate	1590 (1060/530)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F8BABA	182.668756060237	1
Simvastatin	Fenofibrate	0.383	-2.55	Major	2446 (744/1702)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#B1CFE5	281.011180706503	1
Ceftazidime	Gentamicin	1	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Tramadol	Escitalopram	0.199	2.75	Major	1187 (895/292)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F7B7B7	136.369693989623	1
Acetylsalicylic acid	Insulin glulisine	0.26	-2.31	Moderate	464 (151/313)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#B1CFE5	53.307108686761	7.17161988365712e-66
Cholestyramine	Ursodeoxycholic acid	0.28	1.832	None	73 (49/24)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F8BABA	8.38667873735679	1.64128275329702e-40
Carbamazepine	Simvastatin	0.362	1.103	Moderate	758 (418/340)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#F9BCBC	87.0835956563897	1
Bisoprolol	Salbutamol	0.154	-1.502	Moderate	1965 (837/1128)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#B4D1E6	225.751009848029	1
Tacrolimus	Atorvastatin	0.409	-1.914	Moderate	807 (297/510)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#B2D0E5	92.7130101513279	7.40509527146753e-13
Alprazolam	Clarithromycin	0.119	3.229	Moderate	1122 (878/244)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F7B7B7	128.902103333073	1
Omeprazole	Flurazepam	0.249	2.04	Moderate	599 (416/183)		#F8BABA	68.816720050366	1
Omeprazole	Midazolam	0.266	1.486	Moderate	603 (376/227)		#F9BCBC	69.2762640907691	1
Spironolactone	Enalapril	0.37	-2.953	Major	1595 (437/1158)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#AFCEE4	183.243186110741	1
Raloxifene	Estriol	0.21	72.68	None	164 (162/2)		#B32020	18.8413056565276	1.83340014378634e-40
Phenytoin	Lamotrigine	0.537	-1.313	Moderate	61 (28/33)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#B4D1E6	7.00804661614746	1.51522446605041e-41
Propranolol	Paroxetine	0.33	2.903	Moderate	449 (343/106)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F7B7B7	51.5838185352493	1
Bisoprolol	Insulin aspart	0.312	-2.414	Moderate	763 (241/522)		#B1CFE5	87.6580257068936	3.65670165759497e-08
Cyclosporine	Allopurinol	0.39	-3.817	Moderate	177 (40/137)		#ACCCE3	20.3348237878377	6.19829340668335e-49
Diltiazem	Amiodarone	0.354	-2.333	Major	198 (64/134)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#B1CFE5	22.747429999954	3.98222507814067e-46
Fluconazole	Simvastatin	0.097	1.2	Major	1110 (635/475)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	127.523471211864	1
Simvastatin	Gemfibrozil	0.235	-2.365	Major	1989 (637/1352)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#B1CFE5	228.508274090447	1
Bisoprolol	Formoterol	0.211	-1.693	Moderate	1267 (503/764)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#B2D0E5	145.560574797686	1
Acetylsalicylic acid	Acenocoumarol	0.273	-3.907	None	1888 (419/1469)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#ACCCE3	216.904787070269	1
Atenolol	Glyburide	0.329	-1.728	Moderate	602 (236/366)	Atenolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	69.1613780806684	1
Levothyroxine	Iron	0.16	7.554	Moderate	405 (362/43)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#F1ABAB	46.5288340908151	1
Ibuprofen	Carvedilol	0.123	-1.495	Moderate	1517 (648/869)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#B4D1E6	174.28207732288	1
Fluvoxamine	Clomipramine	0.481	1.495	Major	64 (40/24)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#F9BCBC	7.35270464644979	9.88832170205198e-35
Trazodone	Donepezil	0.332	1.346	Moderate	70 (42/28)		#F9BCBC	8.04202070705446	1.54356445181553e-34
Atenolol	Salbutamol	0.137	1.001	Moderate	1189 (627/562)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#F9BCBC	136.599466009825	1
Fluoxetine	Clomipramine	0.326	2.187	Major	275 (195/80)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F7B9B9	31.593652777714	6.65956542735199e-16
Omeprazole	Halazepam	0.248	2.345	Moderate	430 (311/119)		#F7B9B9	49.4009843433345	1
Venlafaxine	Metoclopramide	0.139	3.069	Moderate	526 (407/119)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F7B7B7	60.4300413130092	1
Carbamazepine	Atorvastatin	0.347	-1.179	Moderate	389 (189/200)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#B4D1E6	44.6906579292026	1
Repaglinide	Glyburide	0.205	-1.425	None	221 (97/124)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#B4D1E6	25.3898082322719	4.74256598251867e-08
Phenytoin	Omeprazole	0.331	-1.564	Moderate	685 (285/400)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#B2D0E5	78.6969169190329	1
Acetaminophen	Warfarin	0.227	-1.494	Minor	777 (332/445)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B4D1E6	89.2664298483045	1
Amitriptyline	Salbutamol	0.187	3.022	Moderate	760 (586/174)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#F7B7B7	87.3133676765913	1
Carvedilol	Insulin aspart	0.291	-3.658	Moderate	364 (85/279)		#AECDE3	41.8185076766832	3.70873648910218e-68
Methotrexate	Amoxicillin	0.109	1.466	Major	893 (554/339)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F9BCBC	102.593207019995	1
Tacrolimus	Nifedipine	0.425	-2.148	Moderate	161 (55/106)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#B1CFE5	18.4966476262253	1.67893074989367e-52
Amiodarone	Flecainide	0.163	-1.788	Major	112 (43/69)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#B2D0E5	12.8672331312871	1.44676833944889e-26
Atorvastatin	Clarithromycin	0.09	-1.018	Major	1129 (590/539)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#B4D1E6	129.706305403778	1
Propranolol	Escitalopram	0.305	1.656	None	313 (203/110)		#F8BABA	35.9593211615435	0.239568325171427
Ibuprofen	Acenocoumarol	0.123	-1.49	None	1802 (771/1031)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	207.024590201602	1
Fluoxetine	Propranolol	0.317	2.475	Moderate	327 (240/87)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F7B9B9	37.5677253029544	1
Citalopram	Propranolol	0.317	2.103	Moderate	408 (286/122)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F8BABA	46.8734921211174	1
Simvastatin	Itraconazole	0.098	1.295	Major	838 (495/343)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#F9BCBC	96.274476464452	1
Prednisone	Acenocoumarol	0.172	-1.587	None	817 (337/480)		#B2D0E5	93.8618702523356	1
Sucralfate	Lansoprazole	0.336	1.628	Moderate	152 (98/54)		#F8BABA	17.4626735353183	4.82950153973714e-17
Valproic acid	Acetylsalicylic acid	0.35	-2.224	Moderate	623 (208/415)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#B1CFE5	71.5739842927847	1
Cyclosporine	Omeprazole	0.384	-1.873	Moderate	571 (213/358)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B2D0E5	65.5999117675442	1
Ranolazine	Diltiazem	0.393	-1.796	Major	47 (18/29)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#B2D0E5	5.39964247473657	4.99029585179341e-19
Haloperidol	Lithium cation	0.309	-1.843	Major	69 (26/43)	Lithium may increase the neurotoxic activities of Haloperidol.	#B2D0E5	7.92713469695368	3.47508109421768e-41
Indomethacin	Alendronic acid	0.211	7.013	Moderate	335 (297/38)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#F2ACAC	38.4868133837606	1
Fluvoxamine	Olanzapine	0.431	-1.191	Moderate	60 (29/31)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#B4D1E6	6.89316060604668	1.8255570489465e-31
Citalopram	Acenocoumarol	0.316	-1.218	None	586 (280/306)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#B4D1E6	67.3232019190559	1
Spironolactone	Losartan	0.357	-1.944	Major	505 (184/321)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#B2D0E5	58.0174351008929	1
Trimethoprim	Rifampicin	0.698	-2.322	Moderate	74 (24/50)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#B1CFE5	8.50156474745757	5.07914959416976e-39
Citalopram	Clarithromycin	0.112	4.038	Major	583 (477/106)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#F5B4B4	66.9785438887536	1
Fluconazole	Alprazolam	0.145	2.413	Major	439 (320/119)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F7B9B9	50.4349584342415	1
Propranolol	Sertraline	0.317	1.823	Moderate	291 (195/96)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F8BABA	33.4318289393264	1
Methotrexate	Ibuprofen	0.164	2.041	Major	740 (514/226)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F8BABA	85.0156474745757	1
Dextromethorphan	Paroxetine	0.137	3.865	Major	483 (392/91)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F5B4B4	55.4899428786758	1
Bisoprolol	Glyburide	0.298	-2.834	Moderate	737 (208/529)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#AFCEE4	84.6709894442734	1
Atorvastatin	Gemfibrozil	0.28	-3.503	Major	1127 (272/855)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#AECDE3	129.476533383577	1
Metformin	Glucosamine	0.174	1.096	None	853 (469/384)		#F9BCBC	97.9977666159636	1
Methotrexate	Acetylsalicylic acid	0.246	-1.505	Major	564 (240/324)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#B4D1E6	64.7957096968388	1
Trihexyphenidyl	Haloperidol	0.612	-2.09	Moderate	23 (8/15)		#B2D0E5	2.64237823231789	6.64103790639131e-21
Amitriptyline	Carbamazepine	0.38	1.702	Moderate	168 (110/58)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F8BABA	19.3008496969307	7.46902112374707e-10
Fluoxetine	Acenocoumarol	0.297	1.461	None	347 (215/132)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F9BCBC	39.86544550497	1
Gliclazide	Carvedilol	0.315	-3.412	None	463 (114/349)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#AECDE3	53.1922226766602	3.64089183136609e-07
Fenofibrate	Rosuvastatin	0.466	-3.711	Major	420 (97/323)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#AECDE3	48.2521242423268	4.11930434993066e-42
Topiramate	Carbamazepine	0.519	-1.049	Moderate	99 (51/48)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#B4D1E6	11.373714999977	2.98996880599473e-31
Digoxin	Levothyroxine	0.296	2.052	Moderate	286 (199/87)		#F8BABA	32.8573988888225	1
Simvastatin	Amiodarone	0.29	-2.956	Major	935 (256/679)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#AFCEE4	107.418419444227	1
Erythromycin	Simvastatin	0.086	1.5	Major	577 (361/216)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#F9BCBC	66.2892278281489	1
Acetylsalicylic acid	Glipizide	0.367	-2.76	Moderate	226 (65/161)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#AFCEE4	25.9642382827758	9.15003169673647e-21
Ramipril	Spironolactone	0.404	-2.786	Major	329 (94/235)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#AFCEE4	37.797497323156	5.23377039558151e-07
Carbamazepine	Risperidone	0.425	-1.701	Moderate	96 (38/58)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#B2D0E5	11.0290569696747	4.85761100170019e-32
Acetylsalicylic acid	Ginkgo biloba	0.229	-1.138	Moderate	384 (190/194)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#B4D1E6	44.1162278786988	1
Verapamil	Atorvastatin	0.43	-1.614	Moderate	333 (136/197)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	38.2570413635591	1
Levofloxacin	Acenocoumarol	0.102	-1.779	None	540 (208/332)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	62.0384454544201	1
Bisoprolol	Repaglinide	0.323	-3.411	Moderate	605 (149/456)		#AECDE3	69.5060361109707	1
Ranitidine	Acenocoumarol	0.294	-1.598	None	443 (182/261)		#B2D0E5	50.8945024746447	1
Fluoxetine	Clarithromycin	0.106	4.302	Moderate	423 (350/73)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#F5B4B4	48.5967822726291	1
Paroxetine	Acenocoumarol	0.307	1.133	None	414 (231/183)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	47.5628081817221	1
Cyclosporine	Atorvastatin	0.398	-2.145	Major	193 (66/127)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#B1CFE5	22.1729999494502	4.30512560279348e-14
Ezetimibe	Cholestyramine	0.232	1.161	Moderate	78 (44/34)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	8.96110878786068	3.67858868146445e-10
Bisoprolol	Salmeterol	0.257	-2.521	Moderate	858 (263/595)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#B1CFE5	98.5721966664675	1
Folic acid	Phenobarbital	0.233	1.033	Moderate	71 (38/33)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#F9BCBC	8.15690671715524	1.54835273624662e-12
Fluoxetine	Nortriptyline	0.374	4.586	Major	55 (46/9)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F5B2B2	6.31873055554279	9.44139012570245e-11
Trazodone	Rivastigmine	0.307	-1.516	Moderate	59 (25/34)		#B4D1E6	6.7782745959459	5.30695412558719e-30
Carvedilol	Insulin detemir	0.279	-2.482	Moderate	142 (44/98)		#B1CFE5	16.3138134343105	1.11386330966441e-19
Topiramate	Lithium cation	0.344	2.213	Moderate	52 (37/15)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#F7B9B9	5.97407252524046	1.48803152987675e-11
Cyclosporine	Nifedipine	0.468	-2.898	Moderate	54 (15/39)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#AFCEE4	6.20384454544201	1.98467678831458e-30
Salbutamol	Carvedilol	0.154	-2.044	Major	564 (199/365)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#B2D0E5	64.7957096968388	1
Hydrocortisone	Acetylsalicylic acid	0.174	-1.837	Moderate	723 (273/450)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#B2D0E5	83.0625853028625	1
Fluoxetine	Dextromethorphan	0.133	4.223	Major	331 (273/58)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F5B4B4	38.0272693433575	1
Mesalazine	Mercaptopurine	0.386	-3.343	Moderate	20 (5/15)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#AECDE3	2.29772020201556	6.07190867073641e-23
Methimazole	Acenocoumarol	0.251	-1.277	None	103 (48/55)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#B4D1E6	11.8332590403801	1.13741880571018e-12
Cyclosporine	Carvedilol	0.507	-2.285	Moderate	61 (20/41)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#B1CFE5	7.00804661614746	1.44440630156662e-17
Enalapril	Tizanidine	0.147	1.033	Major	428 (229/199)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#F9BCBC	49.171212323133	1
Paroxetine	Risperidone	0.35	1.33	Moderate	206 (123/83)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#F9BCBC	23.6665180807603	1
Ciprofloxacin	Acenocoumarol	0.107	-2.486	None	701 (217/484)		#B1CFE5	80.5350930806454	1
Sertraline	Carvedilol	0.323	-1.076	Moderate	230 (117/113)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#B4D1E6	26.4237823231789	1
Aprepitant	Dexamethasone	0.625	-1.114	Moderate	2 (1/1)	The serum concentration of Dexamethasone can be increased when it is combined with Aprepitant.	#B4D1E6	0.229772020201556	0.460990394395384
Digoxin	Hydrochlorothiazide	0.304	-1.25	Moderate	348 (164/184)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#B4D1E6	39.9803315150707	1
Glimepiride	Gemfibrozil	0.329	-3.343	Moderate	240 (60/180)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#AECDE3	27.5726424241867	1.30411912558909e-07
Ibuprofen	Lithium cation	0.139	1.534	Moderate	382 (241/141)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F9BCBC	43.8864558584972	1
Acetylsalicylic acid	Methylprednisolone	0.195	-2.021	Moderate	647 (230/417)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#B2D0E5	74.3312485352034	1
Phenytoin	Vigabatrin	0.868	-1.114	Minor	4 (2/2)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#B4D1E6	0.459544040403112	0.00682945727676083
Digoxin	Alprazolam	0.271	1.32	Moderate	252 (150/102)		#F9BCBC	28.9512745453961	1
Diazepam	Clarithromycin	0.243	2.634	Moderate	736 (549/187)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F7B9B9	84.5561034341726	1
Paroxetine	Carvedilol	0.332	-1.077	Moderate	293 (149/144)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#B4D1E6	33.661600959528	1
Atenolol	Insulin aspart	0.274	-1.681	Moderate	306 (122/184)		#B2D0E5	35.1551190908381	1
Simvastatin	Colchicine	0.18	-6.451	Major	1059 (156/903)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#A6C7E0	121.664284696724	1
Sertraline	Clarithromycin	0.116	2.886	Moderate	350 (267/83)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F7B7B7	40.2101035352723	1
Sumatriptan	Ergotamine	0.299	2.121	Major	37 (26/11)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#F7B9B9	4.25078237372879	5.34503745108454e-14
Fluoxetine	Risperidone	0.378	1.256	Moderate	168 (98/70)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#F9BCBC	19.3008496969307	1
Atenolol	Repaglinide	0.299	-1.793	Moderate	287 (110/177)		#B2D0E5	32.9722848989233	1
Propranolol	Primidone	0.323	-2.486	Moderate	42 (13/29)	The metabolism of Propranolol can be increased when combined with Primidone.	#B1CFE5	4.82521242423268	6.38308238570416e-28
Zolmitriptan	Ergotamine	0.303	2.61	Major	43 (32/11)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F7B9B9	4.94009843433345	2.15258681084204e-12
Duloxetine	Ciprofloxacin	0.129	1.953	Major	378 (259/119)		#F8BABA	43.4269118180941	1
Fluoxetine	Carvedilol	0.348	1.33	Moderate	206 (123/83)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#F9BCBC	23.6665180807603	1
Fluoxetine	Lithium cation	0.386	1.365	Major	121 (73/48)	Lithium may increase the serotonergic activities of Fluoxetine.	#F9BCBC	13.9012072221941	1.5678445309043e-05
Salbutamol	Clomipramine	0.156	2.211	Moderate	239 (170/69)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#F7B9B9	27.4577564140859	1
Azithromycin	Acenocoumarol	0.102	-1.269	None	526 (246/280)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#B4D1E6	60.4300413130092	1
Atenolol	Formoterol	0.168	-1.233	Moderate	535 (254/281)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#B4D1E6	61.4640154039162	1
Folic acid	Phenytoin	0.318	-1.635	Moderate	74 (30/44)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#B2D0E5	8.50156474745757	5.9505852677795e-13
Pyridostigmine	Prednisone	0.365	-2.424	Moderate	127 (40/87)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#B1CFE5	14.5905232827988	3.62052650548161e-36
Alprazolam	Carbamazepine	0.277	1.705	Moderate	203 (133/70)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F8BABA	23.3218600504579	1
Zolmitriptan	Escitalopram	0.235	6.77	Major	94 (83/11)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#F2ACAC	10.7992849494731	1
Bisoprolol	Insulin detemir	0.275	-2.191	Moderate	264 (89/175)		#B1CFE5	30.3299066666054	1
Glyburide	Carvedilol	0.315	-3.505	Moderate	257 (62/195)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#AECDE3	29.5257045958999	6.2341073204856e-05
Methotrexate	Diclofenac	0.21	1.264	Major	395 (231/164)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F9BCBC	45.3799739898073	1
Fluconazole	Atorvastatin	0.123	-1.305	Major	419 (193/226)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#B4D1E6	48.137238232226	1
Formoterol	Carvedilol	0.21	-2.051	Major	321 (113/208)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#B2D0E5	36.8784092423497	1
Omeprazole	Cilostazol	0.258	-8.04	Major	920 (112/808)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#A2C4DE	105.695129292716	1
Citalopram	Carvedilol	0.374	-1.599	Moderate	336 (138/198)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#B2D0E5	38.6016993938614	1
Trazodone	Galantamine	0.327	-1.513	Moderate	33 (14/19)		#B4D1E6	3.79123833332567	8.67605188027269e-17
Glimepiride	Repaglinide	0.219	-2.173	None	118 (40/78)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#B1CFE5	13.5565491918918	0.000397942325697718
Haloperidol	Carbamazepine	0.337	-2.006	Moderate	56 (20/36)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#B2D0E5	6.43361656564357	5.39655142298303e-20
Sulfasalazine	Mercaptopurine	0.427	Inf	Moderate	2 (2/0)		#B32020	0.229772020201556	1
Repaglinide	Carvedilol	0.341	-4.339	Moderate	230 (47/183)		#ACCCE3	26.4237823231789	1.73073799064756e-19
Phenytoin	Quetiapine	0.421	-1.599	Major	56 (23/33)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#B2D0E5	6.43361656564357	9.97713145354869e-14
Carbamazepine	Imatinib	0.12	Inf	Moderate	1 (1/0)	The serum concentration of Imatinib can be decreased when it is combined with Carbamazepine.	#B32020	0.114886010100778	1
Atenolol	Insulin detemir	0.259	-1.427	Moderate	171 (75/96)		#B4D1E6	19.645507727233	1
Zolmitriptan	Paroxetine	0.269	4.89	Major	129 (109/20)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#F5B2B2	14.8202953030004	1
Tramadol	Carbamazepine	0.26	1.216	Moderate	252 (145/107)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F9BCBC	28.9512745453961	1
Phenytoin	Furosemide	0.29	-1.477	Minor	93 (40/53)	Phenytoin may decrease the diuretic activities of Furosemide.	#B4D1E6	10.6843989393724	0.00662703052238155
Carvedilol	Escitalopram	0.358	-1.294	None	201 (93/108)		#B4D1E6	23.0920880302564	1
Escitalopram	Rasagiline	0.322	-1.114	Major	68 (34/34)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#B4D1E6	7.8122486868529	3.56655582386544e-06
Alprazolam	Itraconazole	0.126	2.426	Major	263 (192/71)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F7B9B9	30.2150206565046	1
Sumatriptan	Paroxetine	0.224	5.144	Major	101 (86/15)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#F4B1B1	11.6034870201786	1
Cyclosporine	Ursodeoxycholic acid	0.401	-3.258	Minor	51 (13/38)		#AECDE3	5.85918651513968	5.11796981343449e-33
Zolmitriptan	Fluoxetine	0.259	7.423	Major	102 (91/11)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#F1ABAB	11.7183730302794	1
Citalopram	Rizatriptan	0.246	5.542	Major	122 (105/17)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#F3AFAF	14.0160932322949	1
Fluoxetine	Rizatriptan	0.226	8.773	Major	97 (88/9)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#F0A7A7	11.1439429797755	1
Rizatriptan	Escitalopram	0.212	6.036	Major	85 (74/11)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#F2AEAE	9.76531085856613	1
Olanzapine	Donepezil	0.365	1.666	Moderate	20 (13/7)		#F8BABA	2.29772020201556	5.93544419340146e-05
Carbamazepine	Sertraline	0.348	1.821	Moderate	103 (69/34)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#F8BABA	11.8332590403801	1
Indomethacin	Losartan	0.146	-1.548	Moderate	356 (149/207)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#B4D1E6	40.899419595877	1
Prazosin	Nadolol	0.404	-1.672	Moderate	5 (2/3)	Nadolol may increase the orthostatic hypotensive activities of Prazosin.	#B2D0E5	0.57443005050389	0.000142992294301925
Sulfasalazine	Azathioprine	0.474	1.196	Moderate	14 (8/6)		#F9BCBC	1.60840414141089	8.53421852887723e-06
Propranolol	Ergotamine	0.276	4.823	Moderate	51 (43/8)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F5B2B2	5.85918651513968	0.568635386624977
Diltiazem	Amlodipine	0.345	-2.733	Moderate	397 (115/282)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#AFCEE4	45.6097460100089	1
Propranolol	Salbutamol	0.174	-1.109	Major	391 (196/195)		#B4D1E6	44.9204299494042	1
Citalopram	Zolmitriptan	0.189	5.489	Major	121 (104/17)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#F3AFAF	13.9012072221941	1
Azathioprine	Acenocoumarol	0.34	-1.149	None	65 (32/33)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#B4D1E6	7.46759065655057	0.570176620854052
Digoxin	Diazepam	0.238	1.205	Moderate	253 (145/108)		#F9BCBC	29.0661605554968	1
Mirtazapine	Rivastigmine	0.389	1.066	Moderate	35 (19/16)		#F9BCBC	4.02101035352723	2.22130509303983e-08
Fluoxetine	Carbamazepine	0.318	2.692	Moderate	100 (75/25)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#F7B7B7	11.4886010100778	1
Paroxetine	Rizatriptan	0.265	5.922	Major	114 (99/15)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#F3AFAF	13.0970051514887	1
Fluconazole	Fentanyl	0.365	-1.874	Major	177 (66/111)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#B2D0E5	20.3348237878377	8.30029958398461e-06
Atenolol	Terbutaline	0.114	1.523	Moderate	205 (129/76)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#F9BCBC	23.5516320706595	1
Erythromycin	Alprazolam	0.116	2.413	Moderate	214 (156/58)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F7B9B9	24.5856061615665	1
Metoprolol	Ibuprofen	0.137	1.06	Moderate	229 (124/105)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#F9BCBC	26.3088963130782	1
Bisoprolol	Terbutaline	0.101	-1.099	Moderate	284 (143/141)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	32.627626868621	1
Fluvoxamine	Lithium cation	0.34	1.346	Major	20 (12/8)	Lithium may increase the serotonergic activities of Fluvoxamine.	#F9BCBC	2.29772020201556	6.86471335898119e-07
Phenytoin	Topiramate	0.453	-1.29	Moderate	41 (19/22)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#B4D1E6	4.7103264141319	7.54556333591284e-11
Fluvastatin	Acenocoumarol	0.37	-1.899	None	146 (54/92)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#B2D0E5	16.7733574747136	1
Imipramine	Fluoxetine	0.322	3.215	Major	55 (43/12)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F7B7B7	6.31873055554279	0.0592014494081142
Levothyroxine	Cholestyramine	0.191	6.281	Moderate	104 (91/13)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#F2AEAE	11.9481450504809	1
Enalapril	Lithium cation	0.278	-1.105	Moderate	231 (116/115)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#B4D1E6	26.5386683332797	1
Ergotamine	Rizatriptan	0.18	3.205	Major	32 (25/7)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#F7B7B7	3.6763523232249	2.44912151919573e-06
Spironolactone	Irbesartan	0.358	-2.09	Major	138 (48/90)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#B2D0E5	15.8542693939074	1
Indomethacin	Atenolol	0.158	-2.045	Moderate	326 (115/211)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#B2D0E5	37.4528392928536	1
Phenytoin	Oxcarbazepine	0.399	-1.857	Moderate	24 (9/15)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#B2D0E5	2.75726424241867	4.36766933712209e-10
Phenytoin	Acenocoumarol	0.356	-1.393	None	54 (24/30)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	6.20384454544201	1
Ibuprofen	Nadolol	0.177	1.852	Moderate	193 (130/63)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#F8BABA	22.1729999494502	1
Phenytoin	Dexamethasone	0.454	-2.288	Moderate	58 (19/39)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#B1CFE5	6.66338858584512	8.17456775041157e-12
Citalopram	Oxycodone	0.3	1.707	Moderate	119 (78/41)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F8BABA	13.6714352019926	1
Lidocaine	Bisoprolol	0.132	1.317	Moderate	153 (91/62)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#F9BCBC	17.577559545419	1
Bisoprolol	Insulin glulisine	0.28	-1.978	Moderate	111 (40/71)		#B2D0E5	12.7523471211864	1
Phenytoin	Gabapentin	0.46	-1.369	Moderate	78 (35/43)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#B4D1E6	8.96110878786068	0.0901319971507925
Fluconazole	Diazepam	0.242	1.838	Moderate	317 (213/104)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F8BABA	36.4188652019466	1
Triamcinolone	Acetylsalicylic acid	0.121	-2.121	Moderate	450 (155/295)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#B1CFE5	51.6987045453501	1
Dihydroergotamine	Fluoxetine	0.193	8.375	Major	62 (56/6)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#F0A7A7	7.12293262624824	1
Fluoxetine	Ergotamine	0.235	8.46	Major	73 (66/7)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#F0A7A7	8.38667873735679	1
Indomethacin	Furosemide	0.253	-1.689	Moderate	249 (99/150)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#B2D0E5	28.6066165150937	1
Oxycodone	Paroxetine	0.225	2.588	Moderate	101 (75/26)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#F7B9B9	11.6034870201786	1
Warfarin	Acetylsalicylic acid	0.245	-3.343	Major	268 (67/201)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#AECDE3	30.7894507070085	1
Fenofibrate	Acenocoumarol	0.314	-4.525	None	334 (66/268)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#ABCBE2	38.3719273736599	1
Atorvastatin	Colchicine	0.192	-8.585	Major	557 (64/493)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#A0C3DD	63.9915076261333	1
Lovastatin	Verapamil	0.474	1.495	Major	40 (25/15)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#F9BCBC	4.59544040403112	0.319744312780058
Norfloxacin	Acenocoumarol	0.101	1.346	None	215 (129/86)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	24.7004921716673	1
Trospium	Solifenacin	0.2	2.692	Moderate	16 (12/4)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#F7B7B7	1.83817616161245	0.00399099285758847
Sucralfate	Clodronic acid	0.125	Inf	None	1 (1/0)		#B32020	0.114886010100778	1
Torasemide	Indomethacin	0.177	-1.114	Moderate	158 (79/79)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B4D1E6	18.1519895959229	1
Donepezil	Tolterodine	0.317	3.29	Moderate	14 (11/3)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.	#F6B6B6	1.60840414141089	0.064549394246564
Repaglinide	Gemfibrozil	0.264	-3.004	Major	170 (46/124)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#AFCEE4	19.5306217171323	1
Fluoxetine	Oxycodone	0.275	3.041	Moderate	79 (61/18)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#F7B7B7	9.07599479796146	1
Ciprofloxacin	Methotrexate	0.116	1.477	Moderate	172 (107/65)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#F9BCBC	19.7603937373338	1
Citalopram	Sumatriptan	0.297	4.763	Major	82 (69/13)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#F5B2B2	9.4206528282638	1
Methylprednisolone	Clarithromycin	0.54	1.956	Major	159 (109/50)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F8BABA	18.2668756060237	1
Levothyroxine	Warfarin	0.265	1.963	Moderate	102 (70/32)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#F8BABA	11.7183730302794	1
Atenolol	Ergotamine	0.218	3.253	Moderate	74 (58/16)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F6B6B6	8.50156474745757	1
Clozapine	Clonazepam	0.345	1.346	Moderate	10 (6/4)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#F9BCBC	1.14886010100778	0.000454504375988424
Imipramine	Duloxetine	0.197	1.675	Major	43 (28/15)	Duloxetine may increase the serotonergic activities of Imipramine.	#F8BABA	4.94009843433345	0.000236559086451372
Dihydroergotamine	Sumatriptan	0.315	4.486	Major	18 (15/3)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#F5B2B2	2.067948181814	0.00222250989809399
Galantamine	Pimozide	0.023	Inf	Moderate	1 (1/0)	Galantamine may increase the QTc-prolonging activities of Pimozide.	#B32020	0.114886010100778	1
Methotrexate	Flurbiprofen	0.301	-1.532	Major	19 (8/11)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#B4D1E6	2.18283419191478	5.31081056211155e-09
Oxycodone	Sertraline	0.309	3.333	Moderate	66 (52/14)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F6B6B6	7.58247666665135	1
Fluvoxamine	Mirtazapine	0.351	1.025	Major	45 (24/21)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#F9BCBC	5.16987045453501	8.94481416998998e-05
Erythromycin	Atorvastatin	0.098	1.006	Major	210 (111/99)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#F9BCBC	24.1260621211634	1
Almotriptan	Sertraline	0.263	7.717	Major	48 (43/5)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#F0A9A9	5.51452848483734	1
Acetylsalicylic acid	Dexamethasone	0.172	-3.672	Moderate	554 (129/425)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#AECDE3	63.646849595831	1
Indomethacin	Bisoprolol	0.15	-2.827	Moderate	382 (108/274)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#AFCEE4	43.8864558584972	1
Nabumetone	Alendronic acid	0.188	15.254	Moderate	72 (68/4)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#E79494	8.27179272725602	1
Venlafaxine	Almotriptan	0.295	7.178	Major	45 (40/5)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#F1ABAB	5.16987045453501	1
Salmeterol	Carvedilol	0.294	-4.532	Major	304 (60/244)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#ABCBE2	34.9253470706365	1
Atenolol	Salmeterol	0.237	-2.107	Moderate	370 (128/242)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#B2D0E5	42.5078237372879	1
Phenytoin	Diazepam	0.294	-1.571	Moderate	147 (61/86)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#B2D0E5	16.8882434848144	1
Carbamazepine	Aripiprazole	0.399	1.458	Moderate	21 (13/8)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#F9BCBC	2.41260621211634	0.0200892702616964
Pioglitazone	Gemfibrozil	0.341	-2.888	Major	79 (22/57)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#AFCEE4	9.07599479796146	0.14194441601835
Donepezil	Sertraline	0.345	1.032	Minor	43 (23/20)	The metabolism of Donepezil can be decreased when combined with Sertraline.	#F9BCBC	4.94009843433345	0.00196663697171863
Spironolactone	Telmisartan	0.31	-2.167	Major	106 (36/70)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#B1CFE5	12.1779170706825	1
Fenofibrate	Fluvastatin	0.431	-2.757	Major	132 (38/94)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#AFCEE4	15.1649533333027	1
Lorazepam	Phenytoin	0.346	-1.627	Moderate	155 (63/92)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#B2D0E5	17.8073315656206	1
Propranolol	Formoterol	0.203	-1.08	Major	193 (98/95)		#B4D1E6	22.1729999494502	1
Duloxetine	Nortriptyline	0.361	1.311	Major	32 (19/13)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#F9BCBC	3.6763523232249	1.20323241672598e-05
Lidocaine	Propranolol	0.161	3.988	Moderate	49 (40/9)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#F5B4B4	5.62941449493812	1
Fluconazole	Amitriptyline	0.154	2.349	Moderate	123 (89/34)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#F7B9B9	14.1309792423957	1
Propranolol	Gliclazide	0.32	-1.915	None	193 (71/122)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	22.1729999494502	1
Gemfibrozil	Acenocoumarol	0.294	-4.697	None	292 (56/236)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#ABCBE2	33.5467149494272	1
Cyclosporine	Simvastatin	0.39	-1.443	Major	140 (61/79)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#B4D1E6	16.0840414141089	1
Bisoprolol	Verapamil	0.274	-1.28	Major	116 (54/62)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#B4D1E6	13.3267771716902	1
Olanzapine	Rivastigmine	0.325	-1.532	Moderate	19 (8/11)		#B4D1E6	2.18283419191478	9.35143022382653e-06
Lovastatin	Diltiazem	0.411	-1.23	Major	61 (29/32)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#B4D1E6	7.00804661614746	1
Furosemide	Gentamicin	0.183	-1.114	Major	26 (13/13)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#B4D1E6	2.98703626262023	1
Omeprazole	Triazolam	0.284	1.917	Moderate	69 (47/22)		#F8BABA	7.92713469695368	1
Fentanyl	Rifampicin	0.179	-1.2	Major	27 (13/14)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#B4D1E6	3.10192227272101	0.473689568895445
Losartan	Lithium cation	0.317	1.418	Moderate	80 (49/31)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#F9BCBC	9.19088080806224	1
Atenolol	Diltiazem	0.325	-1.705	Major	167 (66/101)	Diltiazem may increase the hypotensive activities of Atenolol.	#B2D0E5	19.1859636868299	1
Almotriptan	Escitalopram	0.267	6.46	Major	41 (36/5)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#F2AEAE	4.7103264141319	1
Acetaminophen	Isoniazid	0.22	-1.356	Moderate	184 (83/101)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#B4D1E6	21.1390258585432	1
Azithromycin	Lovastatin	0.076	1.928	Moderate	148 (101/47)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#F8BABA	17.0031294949151	1
Fluvoxamine	Tramadol	0.191	3.365	Major	76 (60/16)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#F6B6B6	8.73133676765913	1
Digoxin	Telmisartan	0.31	-1.569	Moderate	65 (27/38)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#B2D0E5	7.46759065655057	1
Spironolactone	Cholestyramine	0.244	-2.098	Moderate	49 (17/32)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#B2D0E5	5.62941449493812	9.66257813734937e-05
Cyclosporine	Ciprofloxacin	0.129	-2.415	Moderate	95 (30/65)		#B1CFE5	10.9141709595739	1
Oxycodone	Escitalopram	0.286	1.57	Moderate	66 (42/24)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F8BABA	7.58247666665135	1
Mirtazapine	Donepezil	0.303	1.923	Moderate	22 (15/7)		#F8BABA	2.52749222221712	1
Fluoxetine	Almotriptan	0.271	12.263	Major	44 (41/3)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#EB9C9C	5.05498444443423	1
Diazepam	Itraconazole	0.234	2.015	Moderate	211 (146/65)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F8BABA	24.2409481312642	1
Propranolol	Glyburide	0.298	-1.556	Moderate	115 (48/67)	Propranolol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	13.2118911615895	1
Propranolol	Phenobarbital	0.456	1.795	Moderate	27 (18/9)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#F8BABA	3.10192227272101	1
Spironolactone	Perindopril	0.375	-1.857	Major	40 (15/25)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#B2D0E5	4.59544040403112	1
Trazodone	Acenocoumarol	0.249	-1.427	None	130 (57/73)		#B4D1E6	14.9351813131011	1
Pentoxifylline	Acenocoumarol	0.337	-5.356	None	209 (36/173)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#A9C9E1	24.0111761110626	1
Clozapine	Lamotrigine	0.412	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#B32020	0.229772020201556	1
Erythromycin	Diazepam	0.239	3.372	Moderate	157 (124/33)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F6B6B6	18.0371035858221	1
Carvedilol	Insulin glulisine	0.241	-4.365	Moderate	59 (12/47)		#ABCBE2	6.7782745959459	9.98903894179603e-11
Moxifloxacin	Acenocoumarol	0.073	-2.04	None	150 (53/97)		#B2D0E5	17.2329015151167	1
Rosiglitazone	Gemfibrozil	0.285	-2.486	Moderate	42 (13/29)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#B1CFE5	4.82521242423268	0.15878540257475
Omeprazole	Ketoconazole	0.167	-1.131	Moderate	135 (67/68)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#B4D1E6	15.509611363605	1
Glimepiride	Pregabalin	0.212	-1.662	None	147 (59/88)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#B2D0E5	16.8882434848144	1
Colestipol	Ursodeoxycholic acid	0.287	2.692	None	8 (6/2)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#F7B7B7	0.919088080806224	0.836808001776985
Propranolol	Salmeterol	0.238	-1.376	Major	143 (64/79)		#B4D1E6	16.4286994444113	1
Ziprasidone	Carbamazepine	0.258	1.495	Minor	8 (5/3)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#F9BCBC	0.919088080806224	0.296705951301114
Allopurinol	Warfarin	0.297	-7.015	Moderate	124 (17/107)	Allopurinol may increase the anticoagulant activities of Warfarin.	#A5C6DF	14.2458652524965	1
Sumatriptan	Escitalopram	0.202	5.384	Major	42 (36/6)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#F4B1B1	4.82521242423268	1
Atorvastatin	Itraconazole	0.119	-1.597	Major	236 (97/139)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#B2D0E5	27.1130983837836	1
Hydrochlorothiazide	Lithium cation	0.275	1.229	Major	109 (63/46)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#F9BCBC	12.5225751009848	1
Amitriptyline	Terbutaline	0.185	4.223	Moderate	97 (80/17)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#F5B4B4	11.1439429797755	1
Phenobarbital	Acenocoumarol	0.383	-1.377	None	38 (17/21)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#B4D1E6	4.36566838382956	1
Zolmitriptan	Dihydroergotamine	0.249	6.281	Major	16 (14/2)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F2AEAE	1.83817616161245	1
Clarithromycin	Acenocoumarol	0.099	-1.252	None	189 (89/100)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#B4D1E6	21.713455909047	1
Citalopram	Almotriptan	0.257	5.64	Major	51 (44/7)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#F3AFAF	5.85918651513968	1
Sucralfate	Levothyroxine	0.136	4.901	Minor	84 (71/13)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#F5B2B2	9.65042484846535	1
Colestipol	Levothyroxine	0.203	4.845	Moderate	32 (27/5)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#F5B2B2	3.6763523232249	1
Hydrocortisone	Acenocoumarol	0.152	-1.895	None	135 (50/85)		#B2D0E5	15.509611363605	1
Paroxetine	Almotriptan	0.286	9.646	Major	47 (43/4)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#EEA4A4	5.39964247473657	1
Fluvoxamine	Carbamazepine	0.324	1.154	Moderate	16 (9/7)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#F9BCBC	1.83817616161245	0.101348961352321
Simvastatin	Fusidic acid	0.06	-1.309	None	137 (63/74)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#B4D1E6	15.7393833838066	1
Pantoprazole	Itraconazole	0.184	1.453	Moderate	110 (68/42)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F9BCBC	12.6374611110856	1
Cyclosporine	Sulfamethoxazole	0.259	-8.637	Major	70 (8/62)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#A0C3DD	8.04202070705446	2.13586158600248e-41
Valsartan	Lithium cation	0.222	1.41	Moderate	54 (33/21)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#F9BCBC	6.20384454544201	1
Citalopram	Rasagiline	0.282	1.009	Major	51 (27/24)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#F9BCBC	5.85918651513968	1
Diclofenac	Lithium cation	0.125	1.523	Moderate	116 (73/43)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#F9BCBC	13.3267771716902	1
Pravastatin	Gemfibrozil	0.268	-3.708	Major	238 (55/183)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#AECDE3	27.3428704039852	1
Erythromycin	Fluoxetine	0.132	7.819	Moderate	68 (61/7)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#F0A9A9	7.8122486868529	1
Indomethacin	Propranolol	0.188	1.234	Moderate	76 (44/32)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#F9BCBC	8.73133676765913	1
Perphenazine	Bromocriptine	0.069	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Perphenazine can be decreased when used in combination with Bromocriptine.	#B32020	0.114886010100778	1
Fenofibrate	Ursodeoxycholic acid	0.413	-1.157	None	53 (26/27)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#B4D1E6	6.08895853534123	1
Warfarin	Ibuprofen	0.135	-1.186	Major	192 (93/99)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#B4D1E6	22.0581139393494	1
Fludrocortisone	Rifampicin	0.256	1.795	Moderate	3 (2/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Rifampicin.	#F8BABA	0.344658030302334	1
Doxycycline	Amoxicillin	0.437	-1.001	Moderate	260 (137/123)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#B4D1E6	29.8703626262023	1
Naproxen	Lithium cation	0.136	1.366	Major	111 (67/44)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#F9BCBC	12.7523471211864	1
Enalapril	Rifampicin	0.158	-2.452	None	128 (40/88)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#B1CFE5	14.7054092928996	1
Methotrexate	Phenylbutazone	0.275	-3.343	Major	8 (2/6)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#AECDE3	0.919088080806224	0.000130101234862715
Metoprolol	Prazosin	0.897	Inf	Moderate	1 (1/0)	Metoprolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.114886010100778	1
Trospium	Olanzapine	0.175	Inf	Moderate	6 (6/0)		#B32020	0.689316060604668	1
Carbamazepine	Acenocoumarol	0.332	-2.274	None	76 (25/51)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#B1CFE5	8.73133676765913	1
Megestrol acetate	Primidone	0.156	1.795	Moderate	3 (2/1)		#F8BABA	0.344658030302334	1
Amiodarone	Levofloxacin	0.179	-3.131	Major	160 (42/118)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#AFCEE4	18.3817616161245	1
Cyclosporine	Tacrolimus	0.131	-3.343	Major	32 (8/24)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#AECDE3	3.6763523232249	1.37062656484424e-07
Ranolazine	Simvastatin	0.353	-2.567	Major	109 (33/76)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#B1CFE5	12.5225751009848	1
Sertraline	Rasagiline	0.4	-1.525	Major	45 (19/26)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#B4D1E6	5.16987045453501	1
Prednisone	Phenobarbital	0.172	1.042	Moderate	67 (36/31)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#F9BCBC	7.69736267675213	1
Phenytoin	Sertraline	0.325	1.161	Moderate	39 (22/17)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#F9BCBC	4.48055439393034	1
Citalopram	Metoprolol	0.33	1.73	Moderate	41 (27/14)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F8BABA	4.7103264141319	1
Venlafaxine	Rasagiline	0.324	-1.362	Major	40 (18/22)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.	#B4D1E6	4.59544040403112	1
Cyclosporine	Pravastatin	0.462	-3.184	Major	54 (14/40)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#AFCEE4	6.20384454544201	0.000110641394641338
Fluconazole	Clonazepam	0.172	1.418	None	80 (49/31)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F9BCBC	9.19088080806224	1
Theophylline	Clarithromycin	0.543	1.402	Moderate	41 (25/16)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#F9BCBC	4.7103264141319	1
Metoprolol	Sertraline	0.277	1.795	Moderate	30 (20/10)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#F8BABA	3.44658030302334	1
Fluoxetine	Sumatriptan	0.254	4.262	Major	46 (38/8)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#F5B4B4	5.28475646463579	1
Ziprasidone	Donepezil	0.181	1.795	Moderate	3 (2/1)	The metabolism of Donepezil can be decreased when combined with Ziprasidone.	#F8BABA	0.344658030302334	1
Duloxetine	Flecainide	0.282	1.914	Moderate	47 (32/15)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#F8BABA	5.39964247473657	1
Bupropion	Rasagiline	0.444	-2.229	Major	18 (6/12)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.	#B1CFE5	2.067948181814	0.00176758658764432
Ciprofloxacin	Iron	0.363	-1.069	Moderate	143 (73/70)		#B4D1E6	16.4286994444113	1
Paroxetine	Frovatriptan	0.245	6.73	None	17 (15/2)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#F2ACAC	1.95306217171323	1
Dihydroergotamine	Atenolol	0.228	3.19	Moderate	41 (32/9)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F7B7B7	4.7103264141319	1
Spironolactone	Lisinopril	0.287	-2.447	Major	147 (46/101)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#B1CFE5	16.8882434848144	1
Fluvastatin	Gemfibrozil	0.352	-2.189	Major	83 (28/55)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#B1CFE5	9.53553883836457	1
Erythromycin	Citalopram	0.168	2.961	Major	86 (66/20)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#F7B7B7	9.88019686866691	1
Lovastatin	Acenocoumarol	0.31	-1.82	None	79 (30/49)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#B2D0E5	9.07599479796146	1
Fluvoxamine	Doxepin	0.396	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Doxepin.	#B32020	0.229772020201556	1
Phenytoin	Alprazolam	0.296	-1.053	Moderate	70 (36/34)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#B4D1E6	8.04202070705446	1
Fluoxetine	Doxepin	0.263	Inf	Major	10 (10/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#B32020	1.14886010100778	1
Lovastatin	Carbamazepine	0.349	1.196	None	28 (16/12)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#F9BCBC	3.21680828282178	1
Erythromycin	Acenocoumarol	0.1	-1.01	None	61 (32/29)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#B4D1E6	7.00804661614746	1
Rabeprazole	Itraconazole	0.178	4.088	Moderate	50 (41/9)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#F5B4B4	5.7443005050389	1
Spironolactone	Captopril	0.291	-2.285	Major	61 (20/41)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#B1CFE5	7.00804661614746	1
Paroxetine	Propafenone	0.309	3.028	Moderate	35 (27/8)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#F7B7B7	4.02101035352723	1
Alprazolam	Josamycin	0.094	6.102	None	39 (34/5)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#F2AEAE	4.48055439393034	1
Sotalol	Ibuprofen	0.183	-1.165	Moderate	90 (44/46)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#B4D1E6	10.33974090907	1
Disopyramide	Bisoprolol	0.513	-1.857	Major	8 (3/5)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#B2D0E5	0.919088080806224	0.472818404659619
Trospium	Risperidone	0.44	1.495	Moderate	8 (5/3)		#F9BCBC	0.919088080806224	1
Spironolactone	Tolevamer	0.254	-5.387	Moderate	35 (6/29)		#A9C9E1	4.02101035352723	8.38342488773292e-07
Frovatriptan	Escitalopram	0.277	4.486	Major	12 (10/2)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#F5B2B2	1.37863212120934	1
Alendronic acid	Ketoprofen	0.189	24.227	Moderate	28 (27/1)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#DC7B7B	3.21680828282178	1
Lovastatin	Clarithromycin	0.083	2.039	Major	72 (50/22)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#F8BABA	8.27179272725602	1
Bisoprolol	Ergotamine	0.258	2.692	Moderate	52 (39/13)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F7B7B7	5.97407252524046	1
Fluoxetine	Propafenone	0.295	1.645	Moderate	34 (22/12)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#F8BABA	3.90612434342645	1
Propranolol	Maprotiline	0.323	1.122	Minor	18 (10/8)		#F9BCBC	2.067948181814	0.659025945375628
Rifampicin	Leflunomide	0.187	-2.229	Major	12 (4/8)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#B1CFE5	1.37863212120934	0.00215642817350748
Phenytoin	Prednisone	0.196	-1.3	Moderate	65 (30/35)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#B4D1E6	7.46759065655057	1
Ergotamine	Nadolol	0.241	1.256	Moderate	12 (7/5)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F9BCBC	1.37863212120934	0.600767178222344
Prednisone	Warfarin	0.252	-1.934	Moderate	93 (34/59)	Prednisone may increase the anticoagulant activities of Warfarin.	#B2D0E5	10.6843989393724	1
Atenolol	Verapamil	0.313	-1.428	Major	73 (32/41)	Verapamil may increase the hypotensive activities of Atenolol.	#B4D1E6	8.38667873735679	1
Piroxicam	Alendronic acid	0.139	13.459	None	32 (30/2)	The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.	#E99999	3.6763523232249	1
Capecitabine	Acenocoumarol	0.213	2.094	None	10 (7/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Capecitabine.	#F8BABA	1.14886010100778	1
Phenytoin	Ciprofloxacin	0.103	-2.315	Moderate	80 (26/54)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#B1CFE5	9.19088080806224	1
Gliclazide	Glucosamine	0.184	1.241	None	112 (65/47)		#F9BCBC	12.8672331312871	1
Ergotamine	Almotriptan	0.302	4.038	Major	11 (9/2)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#F5B4B4	1.26374611110856	1
Tramadol	Rasagiline	0.162	-1.25	Major	70 (33/37)	Tramadol may increase the neuroexcitatory activities of Rasagiline.	#B4D1E6	8.04202070705446	1
Naproxen	Acenocoumarol	0.122	-1.337	None	275 (125/150)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	31.593652777714	1
Warfarin	Ranitidine	0.305	-1.824	Moderate	58 (22/36)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#B2D0E5	6.66338858584512	1
Biperiden	Donepezil	0.438	3.589	Moderate	5 (4/1)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.	#F6B6B6	0.57443005050389	1
Dihydroergotamine	Propranolol	0.32	3.813	Moderate	21 (17/4)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F5B4B4	2.41260621211634	1
Carbamazepine	Oxybutynin	0.24	3.14	None	9 (7/2)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#F7B7B7	1.033974090907	1
Digoxin	Methimazole	0.267	-1.783	Moderate	26 (10/16)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#B2D0E5	2.98703626262023	0.375765473359255
Danazol	Acenocoumarol	0.264	1.795	None	3 (2/1)	Danazol may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	0.344658030302334	1
Estradiol	Phenobarbital	0.118	Inf	Moderate	6 (6/0)	The metabolism of Estradiol can be increased when combined with Phenobarbital.	#B32020	0.689316060604668	1
Tizanidine	Lisinopril	0.147	-1.486	Major	84 (36/48)	Tizanidine may increase the hypotensive activities of Lisinopril.	#B4D1E6	9.65042484846535	1
Esomeprazole	Itraconazole	0.22	3.988	Moderate	49 (40/9)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#F5B4B4	5.62941449493812	1
Trazodone	Ginkgo biloba	0.226	3.205	Moderate	32 (25/7)		#F7B7B7	3.6763523232249	1
Cloxacillin	Acenocoumarol	0.075	-2.61	None	137 (41/96)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#B1CFE5	15.7393833838066	1
Clozapine	Midazolam	0.398	-1.114	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.	#B4D1E6	0.229772020201556	1
Prednisone	Itraconazole	0.395	1.703	Moderate	113 (74/39)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#F8BABA	12.9821191413879	1
Omeprazole	Quazepam	0.236	1.147	Moderate	41 (23/18)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#F9BCBC	4.7103264141319	1
Betamethasone	Acetylsalicylic acid	0.091	-1.633	Moderate	106 (43/63)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B2D0E5	12.1779170706825	1
Cyclosporine	Methotrexate	0.185	-1.433	Moderate	16 (7/9)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#B4D1E6	1.83817616161245	1
Lansoprazole	Itraconazole	0.238	1.216	Moderate	73 (42/31)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F9BCBC	8.38667873735679	1
Folic acid	Primidone	0.224	-2.229	Moderate	15 (5/10)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#B1CFE5	1.72329015151167	0.084139287892771
Fentanyl	Amiodarone	0.278	-1.508	Major	40 (17/23)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#B4D1E6	4.59544040403112	1
Warfarin	Paroxetine	0.331	1.615	Moderate	42 (27/15)	Paroxetine may increase the anticoagulant activities of Warfarin.	#F8BABA	4.82521242423268	1
Rosuvastatin	Gemfibrozil	0.283	-4.343	Major	142 (29/113)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#ACCCE3	16.3138134343105	1
Citalopram	Josamycin	0.084	4.128	None	28 (23/5)		#F5B4B4	3.21680828282178	1
Dihydroergotamine	Rizatriptan	0.272	2.243	Major	14 (10/4)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#F7B9B9	1.60840414141089	1
Terbutaline	Carvedilol	0.111	-1.816	Major	71 (27/44)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#B2D0E5	8.15690671715524	1
Methylprednisolone	Phenobarbital	0.084	1.645	Moderate	17 (11/6)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#F8BABA	1.95306217171323	1
Eletriptan	Sertraline	0.322	Inf	Major	12 (12/0)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#B32020	1.37863212120934	1
Prednisone	Estradiol	0.161	34.994	Moderate	40 (39/1)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#CE5D5D	4.59544040403112	1
Amitriptyline	Pseudoephedrine	0.162	5.608	None	58 (50/8)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#F3AFAF	6.66338858584512	1
Itraconazole	Budesonide	0.317	1.032	Major	157 (84/73)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#F9BCBC	18.0371035858221	1
Clarithromycin	Solifenacin	0.162	1.476	Major	82 (51/31)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#F9BCBC	9.4206528282638	1
Verapamil	Colchicine	0.189	-1.911	Major	19 (7/12)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#B2D0E5	2.18283419191478	1
Ergotamine	Itraconazole	0.194	7.178	Major	18 (16/2)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#F1ABAB	2.067948181814	1
Imipramine	Salbutamol	0.148	1.933	Moderate	41 (28/13)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#F8BABA	4.7103264141319	1
Alprazolam	Ketoconazole	0.261	1.994	Major	29 (20/9)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#F8BABA	3.33169429292256	1
Simvastatin	Rifampicin	0.142	-2.353	Major	112 (36/76)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#B1CFE5	12.8672331312871	1
Clomipramine	Rasagiline	0.192	2.094	Major	10 (7/3)	Rasagiline may increase the serotonergic activities of Clomipramine.	#F8BABA	1.14886010100778	1
Clonazepam	Itraconazole	0.151	1.57	None	55 (35/20)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F8BABA	6.31873055554279	1
Fludrocortisone	Phenobarbital	0.27	Inf	Moderate	2 (2/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#B32020	0.229772020201556	1
Methylprednisolone	Rifampicin	0.309	1.025	Moderate	15 (8/7)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#F9BCBC	1.72329015151167	1
Propranolol	Repaglinide	0.261	-2.183	Moderate	71 (24/47)		#B1CFE5	8.15690671715524	1
Trospium	Biperiden	0.427	1.346	Moderate	5 (3/2)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#F9BCBC	0.57443005050389	1
Citalopram	Warfarin	0.3	-1.114	Moderate	52 (26/26)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#B4D1E6	5.97407252524046	1
Lidocaine	Atenolol	0.111	1.137	Moderate	68 (38/30)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#F9BCBC	7.8122486868529	1
Paroxetine	Rasagiline	0.332	-1.173	Major	39 (19/20)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#B4D1E6	4.48055439393034	1
Moclobemide	Clomipramine	0.411	Inf	None	2 (2/0)	Moclobemide may increase the serotonergic activities of Clomipramine.	#B32020	0.229772020201556	1
Cyclosporine	Ezetimibe	0.421	-3.204	Moderate	31 (8/23)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#AFCEE4	3.56146631312412	1
Nabumetone	Acenocoumarol	0.144	-1.463	None	37 (16/21)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	4.25078237372879	1
Fluvoxamine	Duloxetine	0.194	1.346	Major	25 (15/10)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#F9BCBC	2.87215025251945	1
Halazepam	Itraconazole	0.125	Inf	None	10 (10/0)		#B32020	1.14886010100778	1
Methylphenidate	Rasagiline	0.306	2.692	Moderate	4 (3/1)	Rasagiline may increase the hypertensive activities of Methylphenidate.	#F7B7B7	0.459544040403112	1
Imipramine	Carbamazepine	0.331	2.692	Moderate	8 (6/2)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#F7B7B7	0.919088080806224	1
Ciprofloxacin	Sevelamer	0.201	-2.866	Moderate	50 (14/36)		#AFCEE4	5.7443005050389	1
Indomethacin	Bumetanide	0.056	Inf	Moderate	3 (3/0)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Indomethacin.	#B32020	0.344658030302334	1
Atorvastatin	Josamycin	0.068	1.025	None	45 (24/21)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#F9BCBC	5.16987045453501	1
Cyclosporine	Fluconazole	0.254	-3.065	Moderate	30 (8/22)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#AFCEE4	3.44658030302334	0.0208451317714303
Atenolol	Prazosin	0.241	1.795	Moderate	6 (4/2)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#F8BABA	0.689316060604668	1
Spironolactone	Quinapril	0.448	-2.477	Major	29 (9/20)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#B1CFE5	3.33169429292256	1
Sucralfate	Ciprofloxacin	0.433	1.346	Moderate	60 (36/24)		#F9BCBC	6.89316060604668	1
Theophylline	Ciprofloxacin	0.261	-2.026	Major	62 (22/40)		#B2D0E5	7.12293262624824	1
Phenytoin	Levodopa	0.442	-2.508	Moderate	13 (4/9)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#B1CFE5	1.49351813131011	0.69998633740689
Ramipril	Tizanidine	0.117	-1.625	Major	59 (24/35)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#B2D0E5	6.7782745959459	1
Ranitidine	Itraconazole	0.281	1.316	Moderate	74 (44/30)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F9BCBC	8.50156474745757	1
Atorvastatin	Bezafibrate	0.36	-3.467	None	74 (18/56)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#AECDE3	8.50156474745757	1
Metoprolol	Salbutamol	0.112	1.133	Moderate	43 (24/19)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#F9BCBC	4.94009843433345	1
Cyclosporine	Sirolimus	0.065	-4.458	Moderate	5 (1/4)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#ABCBE2	0.57443005050389	0.0376919026802152
Bisoprolol	Epinephrine	0.101	-1.216	Moderate	46 (22/24)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B4D1E6	5.28475646463579	1
Cyclosporine	Diltiazem	0.389	-1.857	Moderate	16 (6/10)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#B2D0E5	1.83817616161245	1
Ergotamine	Frovatriptan	0.311	2.692	Major	4 (3/1)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#F7B7B7	0.459544040403112	1
Fludrocortisone	Acetylsalicylic acid	0.347	-1.274	Moderate	30 (14/16)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#B4D1E6	3.44658030302334	1
Erythromycin	Levofloxacin	0.607	1.206	Moderate	75 (43/32)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F9BCBC	8.61645075755835	1
Tenoxicam	Alendronic acid	0.177	Inf	None	16 (16/0)	The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.	#B32020	1.83817616161245	1
Erythromycin	Digoxin	0.12	2.512	Moderate	19 (14/5)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#F7B9B9	2.18283419191478	1
Disopyramide	Carvedilol	1	Inf	Major	1 (1/0)	Disopyramide may increase the bradycardic activities of Carvedilol.	#B32020	0.114886010100778	1
Ziprasidone	Chlorpromazine	0.25	Inf	Major	1 (1/0)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#B32020	0.114886010100778	1
Spironolactone	Eplerenone	0.088	-10.773	Major	64 (6/58)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#9ABEDB	7.35270464644979	1.73114571215901e-06
Lovastatin	Gemfibrozil	0.336	-1.433	Major	48 (21/27)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#B4D1E6	5.51452848483734	1
Trospium	Galantamine	0.103	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Trospium can be decreased when used in combination with Galantamine.	#B32020	0.114886010100778	1
Ropinirole	Ciprofloxacin	0.125	-1.232	Moderate	40 (19/21)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#B4D1E6	4.59544040403112	1
Galantamine	Biperiden	0.205	1.795	Moderate	3 (2/1)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Galantamine.	#F8BABA	0.344658030302334	1
Glyburide	Glucosamine	0.216	-1.17	None	82 (40/42)		#B4D1E6	9.4206528282638	1
Salbutamol	Nadolol	0.196	-1.243	Major	55 (26/29)		#B4D1E6	6.31873055554279	1
Cyclosporine	Azithromycin	0.143	-1.645	Moderate	52 (21/31)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#B2D0E5	5.97407252524046	1
Metoprolol	Paroxetine	0.455	1.421	Moderate	31 (19/12)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#F9BCBC	3.56146631312412	1
Propranolol	Propafenone	0.328	1.795	Moderate	15 (10/5)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#F8BABA	1.72329015151167	1
Metoprolol	Propafenone	0.448	1.346	Moderate	5 (3/2)	The serum concentration of Metoprolol can be increased when it is combined with Propafenone.	#F9BCBC	0.57443005050389	1
Captopril	Drospirenone	0.036	Inf	Moderate	1 (1/0)	Captopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.114886010100778	1
Hydrocortisone	Phenobarbital	0.187	1.974	Moderate	16 (11/5)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#F8BABA	1.83817616161245	1
Metoprolol	Ergotamine	0.311	Inf	Moderate	5 (5/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.57443005050389	1
Warfarin	Phenobarbital	0.188	-1.114	Major	8 (4/4)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#B4D1E6	0.919088080806224	1
Mirtazapine	Clonidine	0.407	1.346	Moderate	5 (3/2)	Mirtazapine may decrease the antihypertensive activities of Clonidine.	#F9BCBC	0.57443005050389	1
Repaglinide	Clarithromycin	0.133	1.056	Moderate	74 (40/34)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#F9BCBC	8.50156474745757	1
Ranolazine	Amiodarone	0.314	-3.343	Major	12 (3/9)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#AECDE3	1.37863212120934	1
Pregabalin	Pioglitazone	0.249	-1.418	Moderate	50 (22/28)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#B4D1E6	5.7443005050389	1
Fluoxetine	Warfarin	0.282	1.795	Moderate	30 (20/10)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F8BABA	3.44658030302334	1
Propranolol	Terbutaline	0.1	2.14	Major	44 (31/13)		#F7B9B9	5.05498444443423	1
Clozapine	Haloperidol	0.237	-2.229	Major	3 (1/2)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#B1CFE5	0.344658030302334	1
Terbutaline	Clomipramine	0.101	2.064	Moderate	33 (23/10)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#F8BABA	3.79123833332567	1
Metoprolol	Glipizide	0.504	1.795	Moderate	3 (2/1)	Metoprolol may increase the hypoglycemic activities of Glipizide.	#F8BABA	0.344658030302334	1
Theophylline	Verapamil	0.362	-1.337	Moderate	11 (5/6)	The metabolism of Theophylline can be decreased when combined with Verapamil.	#B4D1E6	1.26374611110856	1
Ergotamine	Naratriptan	0.167	1.795	Major	3 (2/1)	Ergotamine may increase the vasoconstricting activities of Naratriptan.	#F8BABA	0.344658030302334	1
Eletriptan	Venlafaxine	0.185	8.973	Major	11 (10/1)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#EFA6A6	1.26374611110856	1
Phenytoin	Fluoxetine	0.412	-1.377	Moderate	38 (17/21)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#B4D1E6	4.36566838382956	1
Clarithromycin	Quetiapine	0.118	1.835	Major	67 (45/22)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F8BABA	7.69736267675213	1
Chlorpropamide	Repaglinide	0.125	Inf	None	1 (1/0)	Chlorpropamide may increase the hypoglycemic activities of Repaglinide.	#B32020	0.114886010100778	1
Galantamine	Sertraline	0.527	-1.592	Moderate	17 (7/10)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#B2D0E5	1.95306217171323	1
Cimetidine	Halazepam	0.028	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Metoprolol	Gliclazide	0.289	-2.837	None	39 (11/28)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	4.48055439393034	1
Methotrexate	Cloxacillin	0.093	2.492	Major	34 (25/9)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F7B9B9	3.90612434342645	1
Spironolactone	Eprosartan	0.352	-1.95	Major	33 (12/21)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#B2D0E5	3.79123833332567	1
Trospium	Tolterodine	0.349	-1.114	Moderate	8 (4/4)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#B4D1E6	0.919088080806224	1
Diltiazem	Tacrolimus	0.315	-2.155	Moderate	44 (15/29)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#B1CFE5	5.05498444443423	1
Mirtazapine	Rasagiline	0.358	-1.61	Major	22 (9/13)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.	#B2D0E5	2.52749222221712	1
Cyclosporine	Ibuprofen	0.13	-1.93	Moderate	112 (41/71)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	12.8672331312871	1
Galantamine	Paroxetine	0.268	2.019	Moderate	13 (9/4)	The metabolism of Galantamine can be decreased when combined with Paroxetine.	#F8BABA	1.49351813131011	1
Phenytoin	Quazepam	0.025	Inf	Moderate	1 (1/0)	The serum concentration of Phenytoin can be increased when it is combined with Quazepam.	#B32020	0.114886010100778	1
Trospium	Quetiapine	0.423	1.122	Moderate	9 (5/4)		#F9BCBC	1.033974090907	1
Levofloxacin	Iron	0.322	1.051	Moderate	76 (41/35)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#F9BCBC	8.73133676765913	1
Amitriptyline	Rasagiline	0.323	-1.114	Major	26 (13/13)	Rasagiline may increase the serotonergic activities of Amitriptyline.	#B4D1E6	2.98703626262023	1
Dihydroergotamine	Carvedilol	0.26	1.795	Moderate	15 (10/5)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F8BABA	1.72329015151167	1
Fluoxetine	Naratriptan	0.369	Inf	Major	6 (6/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Naratriptan.	#B32020	0.689316060604668	1
Rifampicin	Atorvastatin	0.177	-3.081	Major	64 (17/47)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#AFCEE4	7.35270464644979	1
Phenytoin	Megestrol acetate	0.333	-2.972	Moderate	11 (3/8)		#AFCEE4	1.26374611110856	1
Omeprazole	Chlordiazepoxide	0.104	8.076	Moderate	10 (9/1)		#F0A9A9	1.14886010100778	1
Phenytoin	Telithromycin	0.071	Inf	Major	1 (1/0)	The metabolism of Telithromycin can be increased when combined with Phenytoin.	#B32020	0.114886010100778	1
Disopyramide	Omeprazole	0.3	-1.751	None	18 (7/11)		#B2D0E5	2.067948181814	1
Duloxetine	Propafenone	0.236	3.589	Moderate	15 (12/3)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#F6B6B6	1.72329015151167	1
Diclofenac	Rifampicin	0.29	-1.382	Moderate	56 (25/31)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#B4D1E6	6.43361656564357	1
Erythromycin	Sertraline	0.146	2.115	Moderate	47 (33/14)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#F8BABA	5.39964247473657	1
Itraconazole	Solifenacin	0.231	1.631	Major	31 (20/11)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#F8BABA	3.56146631312412	1
Citalopram	Eletriptan	0.24	11.665	Major	14 (13/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#EB9E9E	1.60840414141089	1
Venlafaxine	Naratriptan	0.223	4.486	Major	6 (5/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.	#F5B2B2	0.689316060604668	1
Bromocriptine	Methotrimeprazine	0.179	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Methotrimeprazine can be decreased when used in combination with Bromocriptine.	#B32020	0.114886010100778	1
Citalopram	Naratriptan	0.174	Inf	Major	7 (7/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#B32020	0.804202070705446	1
Atorvastatin	Fusidic acid	0.062	-1.592	None	51 (21/30)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#B2D0E5	5.85918651513968	1
Trospium	Oxybutynin	0.33	1.795	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#F8BABA	0.344658030302334	1
Cyclosporine	Fluvastatin	0.463	-1.56	Moderate	12 (5/7)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#B2D0E5	1.37863212120934	1
Galantamine	Perphenazine	0.263	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Imipramine	Rivastigmine	0.437	1.795	Moderate	3 (2/1)		#F8BABA	0.344658030302334	1
Indomethacin	Carvedilol	0.154	-3.622	Moderate	85 (20/65)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#AECDE3	9.76531085856613	1
Duloxetine	Rasagiline	0.319	-1.114	Major	20 (10/10)	Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.	#B4D1E6	2.29772020201556	1
Norfloxacin	Iron	0.302	2.243	None	56 (40/16)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#F7B9B9	6.43361656564357	1
Ticlopidine	Theophylline	0.023	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Ticlopidine.	#B32020	0.114886010100778	1
Diltiazem	Midazolam	0.397	-1.592	Moderate	17 (7/10)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#B2D0E5	1.95306217171323	1
Fluconazole	Tacrolimus	0.402	-1.486	Major	42 (18/24)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#B4D1E6	4.82521242423268	1
Telithromycin	Acenocoumarol	0.367	Inf	None	3 (3/0)	The metabolism of Acenocoumarol can be decreased when combined with Telithromycin.	#B32020	0.344658030302334	1
Prazosin	Propranolol	0.455	-2.229	Moderate	6 (2/4)	Propranolol may increase the orthostatic hypotensive activities of Prazosin.	#B1CFE5	0.689316060604668	0.426674006626616
Warfarin	Levofloxacin	0.143	-2.848	Major	64 (18/46)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#AFCEE4	7.35270464644979	1
Repaglinide	Glucosamine	0.221	-1.073	None	53 (27/26)		#B4D1E6	6.08895853534123	1
Diltiazem	Rifampicin	0.348	2.243	Major	7 (5/2)	The serum concentration of Diltiazem can be decreased when it is combined with Rifampicin.	#F7B9B9	0.804202070705446	1
Megestrol acetate	Phenobarbital	0.45	Inf	Moderate	3 (3/0)		#B32020	0.344658030302334	1
Warfarin	Fluvastatin	0.192	-1.433	Minor	16 (7/9)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#B4D1E6	1.83817616161245	1
Torasemide	Gentamicin	0.095	2.243	Major	7 (5/2)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#F7B9B9	0.804202070705446	1
Diltiazem	Propranolol	0.294	-1.232	Major	40 (19/21)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#B4D1E6	4.59544040403112	1
Labetalol	Epinephrine	0.087	Inf	Major	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#B32020	0.114886010100778	1
Trospium	Loratadine	0.116	5.384	None	14 (12/2)		#F4B1B1	1.60840414141089	1
Dexamethasone	Acenocoumarol	0.209	-1.874	None	59 (22/37)		#B2D0E5	6.7782745959459	1
Chlorthalidone	Digoxin	0.313	-2.006	Moderate	28 (10/18)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#B2D0E5	3.21680828282178	1
Frovatriptan	Sertraline	0.388	6.281	Major	8 (7/1)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#F2AEAE	0.919088080806224	1
Acarbose	Digoxin	0.332	1.196	Moderate	7 (4/3)	The serum concentration of Digoxin can be decreased when it is combined with Acarbose.	#F9BCBC	0.804202070705446	1
Diazepam	Josamycin	0.295	2.121	None	37 (26/11)		#F7B9B9	4.25078237372879	1
Sertraline	Propafenone	0.408	1.458	Moderate	21 (13/8)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#F9BCBC	2.41260621211634	1
Phenytoin	Midazolam	0.375	-1.857	Moderate	8 (3/5)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#B2D0E5	0.919088080806224	1
Diltiazem	Cilostazol	0.322	-10.309	Major	41 (4/37)	The serum concentration of Cilostazol can be increased when it is combined with Diltiazem.	#9CBFDB	4.7103264141319	0.603083528256684
Galantamine	Maprotiline	0.062	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Rifampicin	Clarithromycin	0.73	-1.579	Moderate	29 (12/17)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#B2D0E5	3.33169429292256	1
Trihexyphenidyl	Donepezil	0.036	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Donepezil.	#B32020	0.114886010100778	1
Verapamil	Lithium cation	0.288	-1.857	Moderate	16 (6/10)	Verapamil may increase the neurotoxic activities of Lithium.	#B2D0E5	1.83817616161245	1
Digoxin	Rabeprazole	0.227	-1.967	Moderate	47 (17/30)		#B2D0E5	5.39964247473657	1
Tizanidine	Norethisterone	0.211	Inf	Major	5 (5/0)		#B32020	0.57443005050389	1
Dihydroergotamine	Frovatriptan	0.542	Inf	Major	2 (2/0)	Dihydroergotamine may increase the vasoconstricting activities of Frovatriptan.	#B32020	0.229772020201556	1
Chlorpropamide	Acetylsalicylic acid	0.141	-1.114	None	6 (3/3)	Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.	#B4D1E6	0.689316060604668	1
Ciprofloxacin	Warfarin	0.13	-3.009	Major	74 (20/54)		#AFCEE4	8.50156474745757	1
Primidone	Metronidazole	0.118	Inf	Moderate	4 (4/0)	The serum concentration of Metronidazole can be decreased when it is combined with Primidone.	#B32020	0.459544040403112	1
Metoprolol	Fluoxetine	0.258	1.666	Moderate	20 (13/7)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#F8BABA	2.29772020201556	1
Clozapine	Sertraline	0.411	1.346	Major	5 (3/2)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#F9BCBC	0.57443005050389	1
Triamcinolone	Warfarin	0.203	7.178	Moderate	9 (8/1)	Triamcinolone may increase the anticoagulant activities of Warfarin.	#F1ABAB	1.033974090907	1
Digoxin	Indapamide	0.314	-1.715	Moderate	33 (13/20)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#B2D0E5	3.79123833332567	1
Phenytoin	Warfarin	0.282	-1.486	Moderate	7 (3/4)	Phenytoin may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.804202070705446	1
Sucralfate	Ibandronate	0.171	Inf	Moderate	13 (13/0)		#B32020	1.49351813131011	1
Cyproheptadine	Fluoxetine	0.324	2.692	Moderate	4 (3/1)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#F7B7B7	0.459544040403112	1
Glimepiride	Glucosamine	0.162	1.645	None	34 (22/12)		#F8BABA	3.90612434342645	1
Ibandronate	Iron	0.213	8.973	Moderate	22 (20/2)		#EFA6A6	2.52749222221712	1
Erythromycin	Methylprednisolone	0.485	-1.377	Moderate	38 (17/21)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#B4D1E6	4.36566838382956	1
Eletriptan	Escitalopram	0.152	7.178	Major	9 (8/1)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#F1ABAB	1.033974090907	1
Mefenamic acid	Acenocoumarol	0.178	-1.114	None	4 (2/2)	Mefenamic acid may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.459544040403112	1
Mirtazapine	Galantamine	0.275	-1.393	Moderate	9 (4/5)		#B4D1E6	1.033974090907	1
Donepezil	Solifenacin	0.203	-1.114	Moderate	10 (5/5)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Donepezil.	#B4D1E6	1.14886010100778	1
Phenytoin	Hydrocortisone	0.241	-2.09	Moderate	23 (8/15)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#B2D0E5	2.64237823231789	1
Haloperidol	Propranolol	0.334	-1.895	Moderate	27 (10/17)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#B2D0E5	3.10192227272101	1
Fluoxetine	Trimipramine	0.076	1.795	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#F8BABA	0.344658030302334	1
Fluvoxamine	Naratriptan	0.75	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Naratriptan.	#B32020	0.114886010100778	1
Spironolactone	Benazepril	0.604	-1.114	Major	4 (2/2)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#B4D1E6	0.459544040403112	1
Dihydroergotamine	Bisoprolol	0.227	-1.17	Moderate	41 (20/21)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B4D1E6	4.7103264141319	1
Metoprolol	Formoterol	0.165	1.196	Moderate	21 (12/9)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#F9BCBC	2.41260621211634	1
Trazodone	Itraconazole	0.178	1.41	Moderate	36 (22/14)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#F9BCBC	4.13589636362801	1
Piroxicam	Methotrexate	0.234	1.077	Major	11 (6/5)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#F9BCBC	1.26374611110856	1
Fluvoxamine	Rizatriptan	0.273	2.243	Major	7 (5/2)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#F7B9B9	0.804202070705446	1
Simvastatin	Ketoconazole	0.145	-1.645	Major	52 (21/31)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#B2D0E5	5.97407252524046	1
Metronidazole	Lithium cation	0.089	1.196	Moderate	21 (12/9)		#F9BCBC	2.41260621211634	1
Rosuvastatin	Colchicine	0.186	-6.965	Moderate	58 (8/50)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#A5C6DF	6.66338858584512	1
Eletriptan	Fluoxetine	0.179	Inf	Major	9 (9/0)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#B32020	1.033974090907	1
Erythromycin	Verapamil	0.181	1.154	Major	16 (9/7)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#F9BCBC	1.83817616161245	1
Warfarin	Fenofibrate	0.265	-4.876	Major	43 (8/35)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#ABCBE2	4.94009843433345	1
Tizanidine	Perindopril	0.077	-1.114	Major	12 (6/6)	The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.	#B4D1E6	1.37863212120934	1
Trospium	Hydroxyzine	0.114	Inf	Moderate	6 (6/0)		#B32020	0.689316060604668	1
Rifabutin	Clarithromycin	0.426	-2.229	Moderate	6 (2/4)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#B1CFE5	0.689316060604668	1
Cyclosporine	Metoclopramide	0.111	-1.722	Moderate	28 (11/17)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#B2D0E5	3.21680828282178	1
Celecoxib	Lithium cation	0.161	1.682	Major	23 (15/8)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#F8BABA	2.64237823231789	1
Levofloxacin	Methotrimeprazine	0.176	-1.881	Moderate	43 (16/27)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#B2D0E5	4.94009843433345	1
Trospium	Ketotifen	0.067	Inf	None	1 (1/0)		#B32020	0.114886010100778	1
Digoxin	Methotrexate	0.164	1.122	Moderate	18 (10/8)	Digoxin may decrease the cardiotoxic activities of Methotrexate.	#F9BCBC	2.067948181814	1
Erythromycin	Lovastatin	0.074	2.692	Major	16 (12/4)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#F7B7B7	1.83817616161245	1
Verapamil	Phenobarbital	0.369	1.196	Moderate	7 (4/3)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#F9BCBC	0.804202070705446	1
Carbamazepine	Felodipine	0.503	2.692	Moderate	4 (3/1)	The metabolism of Felodipine can be increased when combined with Carbamazepine.	#F7B7B7	0.459544040403112	1
Theophylline	Primidone	0.289	-1.114	Moderate	2 (1/1)	The metabolism of Theophylline can be increased when combined with Primidone.	#B4D1E6	0.229772020201556	1
Minocycline	Amoxicillin	0.361	-1.359	Moderate	91 (41/50)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#B4D1E6	10.4546269191708	1
Bisoprolol	Glipizide	0.346	-4.953	Moderate	49 (9/40)	Bisoprolol may increase the hypoglycemic activities of Glipizide.	#A9C9E1	5.62941449493812	1
Metronidazole	Acenocoumarol	0.112	-2.015	None	73 (26/47)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#B2D0E5	8.38667873735679	1
Verapamil	Eplerenone	0.515	-5.201	Moderate	17 (3/14)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#A9C9E1	1.95306217171323	1
Celecoxib	Acenocoumarol	0.126	-1.385	None	74 (33/41)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	8.50156474745757	1
Miglitol	Glucosamine	0.265	1.795	None	6 (4/2)		#F8BABA	0.689316060604668	1
Erythromycin	Moxifloxacin	0.664	2.542	Major	23 (17/6)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F7B9B9	2.64237823231789	1
Leflunomide	Acenocoumarol	0.321	-1.114	None	18 (9/9)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	2.067948181814	1
Fluconazole	Rifabutin	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Rifabutin can be increased when it is combined with Fluconazole.	#B32020	0.114886010100778	1
Metoprolol	Glyburide	0.312	-2.786	Moderate	21 (6/15)	Metoprolol may increase the hypoglycemic activities of Glyburide.	#AFCEE4	2.41260621211634	1
Atenolol	Insulin glulisine	0.227	-1.824	Moderate	29 (11/18)		#B2D0E5	3.33169429292256	1
Ciprofloxacin	Rasagiline	0.095	-3.001	Major	48 (13/35)		#AFCEE4	5.51452848483734	1
Nortriptyline	Carbamazepine	0.404	1.346	Moderate	5 (3/2)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#F9BCBC	0.57443005050389	1
Digoxin	Clarithromycin	0.14	-1.163	Major	47 (23/24)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#B4D1E6	5.39964247473657	1
Rifampicin	Etoricoxib	0.168	7.178	None	9 (8/1)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#F1ABAB	1.033974090907	1
Verapamil	Midazolam	0.15	3.589	Moderate	5 (4/1)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#F6B6B6	0.57443005050389	1
Trimethoprim	Methotrexate	0.234	-1.022	Major	23 (12/11)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#B4D1E6	2.64237823231789	1
Oxcarbazepine	Felodipine	0.437	Inf	Moderate	2 (2/0)		#B32020	0.229772020201556	1
Colestipol	Fluvastatin	0.2	1.346	Moderate	5 (3/2)	Colestipol can cause a decrease in the absorption of Fluvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	0.57443005050389	1
Sumatriptan	Lithium cation	0.288	2.243	None	7 (5/2)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.	#F7B9B9	0.804202070705446	1
Imipramine	Rasagiline	0.494	-1.672	Major	5 (2/3)	Rasagiline may increase the serotonergic activities of Imipramine.	#B2D0E5	0.57443005050389	1
Ramipril	Lithium cation	0.319	-2.432	Moderate	35 (11/24)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#B1CFE5	4.02101035352723	1
Propranolol	Verapamil	0.275	1.645	Major	17 (11/6)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#F8BABA	1.95306217171323	1
Biperiden	Rivastigmine	0.215	-2.229	Moderate	6 (2/4)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Rivastigmine.	#B1CFE5	0.689316060604668	1
Amitriptyline	Epinephrine	0.171	3.888	Major	16 (13/3)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#F5B4B4	1.83817616161245	1
Prednisone	Estriol	0.284	34.994	None	40 (39/1)	The serum concentration of Prednisone can be increased when it is combined with Estriol.	#CE5D5D	4.59544040403112	1
Sotalol	Glyburide	0.257	-1.114	Moderate	8 (4/4)	Sotalol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	0.919088080806224	1
Atenolol	Epinephrine	0.085	-1.029	Moderate	25 (13/12)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B4D1E6	2.87215025251945	1
Pseudoephedrine	Clomipramine	0.043	2.094	None	20 (14/6)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#F8BABA	2.29772020201556	1
Fluconazole	Halazepam	0.156	3.14	None	9 (7/2)		#F7B7B7	1.033974090907	1
Prednisone	Rifampicin	0.35	-3.429	Moderate	53 (13/40)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#AECDE3	6.08895853534123	1
Cimetidine	Propranolol	0.07	Inf	Moderate	2 (2/0)	The metabolism of Propranolol can be decreased when combined with Cimetidine.	#B32020	0.229772020201556	1
Rifampicin	Clomipramine	0.077	1.196	Minor	7 (4/3)	The metabolism of Clomipramine can be increased when combined with Rifampicin.	#F9BCBC	0.804202070705446	1
Olanzapine	Galantamine	0.507	-2.786	Moderate	7 (2/5)		#AFCEE4	0.804202070705446	1
Flurazepam	Itraconazole	0.284	3.14	None	9 (7/2)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#F7B7B7	1.033974090907	1
Alendronic acid	Flurbiprofen	0.11	7.178	Moderate	9 (8/1)	The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.	#F1ABAB	1.033974090907	1
Acitretin	Methotrexate	0.136	-2.6	Major	10 (3/7)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#B1CFE5	1.14886010100778	1
Galantamine	Tolterodine	0.354	-1.672	Moderate	5 (2/3)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.	#B2D0E5	0.57443005050389	1
Lisinopril	Lithium cation	0.276	-1.035	Moderate	27 (14/13)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#B4D1E6	3.10192227272101	1
Tobramycin	Furosemide	0.175	-2.786	Major	7 (2/5)	The serum concentration of Tobramycin can be increased when it is combined with Furosemide.	#AFCEE4	0.804202070705446	1
Metoprolol	Escitalopram	0.348	-1.114	Minor	18 (9/9)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#B4D1E6	2.067948181814	1
Itraconazole	Clarithromycin	0.521	2.61	Moderate	43 (32/11)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#F7B9B9	4.94009843433345	1
Imipramine	Pseudoephedrine	0.073	5.384	None	7 (6/1)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#F4B1B1	0.804202070705446	1
Methotrexate	Benzylpenicillin	0.036	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Benzylpenicillin.	#B32020	0.114886010100778	1
Ergotamine	Clarithromycin	0.216	1.795	Major	30 (20/10)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#F8BABA	3.44658030302334	1
Amitriptyline	Galantamine	0.27	1.122	Moderate	9 (5/4)		#F9BCBC	1.033974090907	1
Warfarin	Azathioprine	0.42	-1.486	Moderate	7 (3/4)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#B4D1E6	0.804202070705446	1
Ticlopidine	Acetylsalicylic acid	0.29	-2.972	Moderate	22 (6/16)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#AFCEE4	2.52749222221712	1
Paroxetine	Naratriptan	0.199	4.486	Major	6 (5/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#F5B2B2	0.689316060604668	1
Sotalol	Formoterol	0.207	-1.433	Major	16 (7/9)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	1.83817616161245	1
Propranolol	Hydralazine	0.491	-2.229	Minor	15 (5/10)	Hydralazine may increase the hypotensive activities of Propranolol.	#B1CFE5	1.72329015151167	1
Fluconazole	Haloperidol	0.645	-3.622	Major	34 (8/26)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#AECDE3	3.90612434342645	1
Torasemide	Amikacin	0.167	Inf	Major	1 (1/0)	The serum concentration of Amikacin can be increased when it is combined with Torasemide.	#B32020	0.114886010100778	1
Fluvastatin	Cholestyramine	0.224	-1.3	Moderate	13 (6/7)	The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.	#B4D1E6	1.49351813131011	1
Dihydroergotamine	Telithromycin	0.071	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Telithromycin.	#B32020	0.114886010100778	1
Pravastatin	Bezafibrate	0.366	-1.486	None	14 (6/8)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#B4D1E6	1.60840414141089	1
Cyclosporine	Fluoxetine	0.289	-1.114	Moderate	18 (9/9)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#B4D1E6	2.067948181814	1
Imatinib	Atorvastatin	0.03	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Imatinib is combined with Atorvastatin.	#B32020	0.114886010100778	1
Warfarin	Leflunomide	0.217	1.346	Moderate	5 (3/2)	Leflunomide may increase the anticoagulant activities of Warfarin.	#F9BCBC	0.57443005050389	1
Atenolol	Isoprenaline	0.143	Inf	Moderate	1 (1/0)	Atenolol may decrease the bronchodilatory activities of Isoprenaline.	#B32020	0.114886010100778	1
Doxycycline	Cloxacillin	0.839	1.944	Moderate	19 (13/6)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#F8BABA	2.18283419191478	1
Lovastatin	Fenofibrate	0.373	1.458	Major	21 (13/8)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#F9BCBC	2.41260621211634	1
Cyclosporine	Digoxin	0.128	-1.486	Moderate	7 (3/4)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#B4D1E6	0.804202070705446	1
Tacrolimus	Metronidazole	0.113	1.025	Moderate	30 (16/14)		#F9BCBC	3.44658030302334	1
Methotrexate	Sulfamethoxazole	0.21	-1.114	Moderate	20 (10/10)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#B4D1E6	2.29772020201556	1
Meloxicam	Acenocoumarol	0.151	1.154	None	32 (18/14)	Meloxicam may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	3.6763523232249	1
Pimozide	Escitalopram	0.219	1.346	Major	5 (3/2)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#F9BCBC	0.57443005050389	1
Doxycycline	Rifampicin	0.36	-1.486	Moderate	7 (3/4)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#B4D1E6	0.804202070705446	1
Tolterodine	Itraconazole	0.114	2.468	Moderate	15 (11/4)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#F7B9B9	1.72329015151167	1
Dihydroergotamine	Almotriptan	0.191	Inf	Major	4 (4/0)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#B32020	0.459544040403112	1
Eletriptan	Paroxetine	0.228	2.692	Major	12 (9/3)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#F7B7B7	1.37863212120934	1
Phenytoin	Mirtazapine	0.273	-2.388	Moderate	22 (7/15)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#B1CFE5	2.52749222221712	1
Ketoconazole	Atorvastatin	0.202	-1.672	Major	25 (10/15)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#B2D0E5	2.87215025251945	1
Fluconazole	Lovastatin	0.064	1.458	Major	21 (13/8)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#F9BCBC	2.41260621211634	1
Dihydroergotamine	Nadolol	0.156	2.692	Moderate	4 (3/1)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F7B7B7	0.459544040403112	1
Fluvoxamine	Amitriptyline	0.297	1.645	Major	17 (11/6)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#F8BABA	1.95306217171323	1
Indapamide	Lithium cation	0.237	1.196	Major	14 (8/6)	Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.	#F9BCBC	1.60840414141089	1
Nabumetone	Methotrexate	0.276	-1.114	Major	14 (7/7)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#B4D1E6	1.60840414141089	1
Amitriptyline	Rivastigmine	0.284	6.281	Moderate	8 (7/1)		#F2AEAE	0.919088080806224	1
Indomethacin	Warfarin	0.135	-1.114	Major	14 (7/7)	Indomethacin may increase the anticoagulant activities of Warfarin.	#B4D1E6	1.60840414141089	1
Atenolol	Glipizide	0.294	-3.025	Moderate	26 (7/19)	Atenolol may increase the hypoglycemic activities of Glipizide.	#AFCEE4	2.98703626262023	1
Sucralfate	Levofloxacin	0.549	-1.672	Moderate	45 (18/27)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#B2D0E5	5.16987045453501	1
Nortriptyline	Salbutamol	0.144	1.346	Moderate	20 (12/8)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#F9BCBC	2.29772020201556	1
Diclofenac	Warfarin	0.149	-2.853	Major	89 (25/64)	Diclofenac may increase the anticoagulant activities of Warfarin.	#AFCEE4	10.2248548989692	1
Cyclosporine	Sevelamer	0.197	-6.687	Moderate	7 (1/6)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#A5C6DF	0.804202070705446	0.0515921269969835
Ergotamine	Carvedilol	0.192	-1.114	Moderate	16 (8/8)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B4D1E6	1.83817616161245	1
Atomoxetine	Fluoxetine	0.5	Inf	Major	2 (2/0)	The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.	#B32020	0.229772020201556	1
Doxycycline	Ethinylestradiol	1	Inf	Moderate	1 (1/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Doxycycline.	#B32020	0.114886010100778	1
Raloxifene	Estradiol	0.116	Inf	Moderate	11 (11/0)		#B32020	1.26374611110856	1
Cyclosporine	Norfloxacin	0.125	-1.114	Moderate	18 (9/9)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#B4D1E6	2.067948181814	1
Labetalol	Verapamil	0.057	-1.114	Major	2 (1/1)	Verapamil may increase the hypotensive activities of Labetalol.	#B4D1E6	0.229772020201556	1
Repaglinide	Glipizide	0.199	-1.486	None	7 (3/4)	Repaglinide may increase the hypoglycemic activities of Glipizide.	#B4D1E6	0.804202070705446	1
Gemfibrozil	Ursodeoxycholic acid	0.354	-1.722	None	28 (11/17)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#B2D0E5	3.21680828282178	1
Lovastatin	Warfarin	0.387	-1.56	Moderate	12 (5/7)	The metabolism of Warfarin can be decreased when combined with Lovastatin.	#B2D0E5	1.37863212120934	1
Eplerenone	Clarithromycin	0.09	-2.353	Major	28 (9/19)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#B1CFE5	3.21680828282178	1
Paroxetine	Pimozide	0.485	3.589	Major	5 (4/1)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#F6B6B6	0.57443005050389	1
Fluconazole	Celecoxib	0.257	2.916	Moderate	34 (26/8)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F7B7B7	3.90612434342645	1
Theophylline	Nadolol	0.056	Inf	Major	2 (2/0)		#B32020	0.229772020201556	1
Pimozide	Sertraline	0.417	2.692	Major	4 (3/1)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#F7B7B7	0.459544040403112	1
Indomethacin	Nadolol	0.214	1.346	Moderate	10 (6/4)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#F9BCBC	1.14886010100778	1
Fluconazole	Acenocoumarol	0.12	-2.291	None	55 (18/37)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#B1CFE5	6.31873055554279	1
Methylergometrine	Nitroglycerin	0.75	-1.114	Moderate	2 (1/1)	The bioavailability of Methylergometrine can be increased when combined with Nitroglycerin.	#B4D1E6	0.229772020201556	1
Acenocoumarol	Etoricoxib	0.114	-1.156	None	55 (27/28)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	6.31873055554279	1
Pregabalin	Rosiglitazone	0.228	1.154	Moderate	16 (9/7)	The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.	#F9BCBC	1.83817616161245	1
Diazepam	Rifampicin	0.303	-1.635	Minor	37 (15/22)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#B2D0E5	4.25078237372879	1
Glyburide	Oxprenolol	0.04	Inf	None	1 (1/0)	Oxprenolol may increase the hypoglycemic activities of Glyburide.	#B32020	0.114886010100778	1
Almotriptan	Itraconazole	0.289	6.281	Moderate	8 (7/1)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#F2AEAE	0.919088080806224	1
Lovastatin	Tacrolimus	0.121	2.019	Moderate	13 (9/4)	The serum concentration of Lovastatin can be increased when it is combined with Tacrolimus.	#F8BABA	1.49351813131011	1
Theophylline	Phenobarbital	0.318	-1.114	Moderate	4 (2/2)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#B4D1E6	0.459544040403112	1
Fluconazole	Tolterodine	0.368	1.974	Moderate	16 (11/5)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#F8BABA	1.83817616161245	1
Lovastatin	Itraconazole	0.153	1.41	Major	18 (11/7)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#F9BCBC	2.067948181814	1
Carbamazepine	Bupropion	0.216	4.486	Moderate	6 (5/1)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#F5B2B2	0.689316060604668	1
Cyclosporine	Glimepiride	0.229	-1.486	Moderate	7 (3/4)	The metabolism of Glimepiride can be decreased when combined with Cyclosporine.	#B4D1E6	0.804202070705446	1
Carbamazepine	Clarithromycin	0.093	1.468	Major	29 (18/11)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#F9BCBC	3.33169429292256	1
Gentamicin	Cefuroxime	0.475	-1.95	Moderate	11 (4/7)		#B2D0E5	1.26374611110856	1
Medroxyprogesterone acetate	Warfarin	0.143	Inf	None	1 (1/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Warfarin.	#B32020	0.114886010100778	1
Fentanyl	Itraconazole	0.105	2.094	Major	20 (14/6)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#F8BABA	2.29772020201556	1
Cyclosporine	Naproxen	0.13	1.224	Moderate	26 (15/11)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#F9BCBC	2.98703626262023	1
Fluconazole	Midazolam	0.197	-1.3	Major	13 (6/7)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#B4D1E6	1.49351813131011	1
Levofloxacin	Josamycin	0.569	1.495	None	16 (10/6)		#F9BCBC	1.83817616161245	1
Fluconazole	Everolimus	0.296	-2.786	Major	7 (2/5)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#AFCEE4	0.804202070705446	1
Piroxicam	Bisoprolol	0.126	-1.013	Moderate	21 (11/10)	Piroxicam may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	2.41260621211634	1
Chlorpromazine	Propranolol	0.323	-2.6	Moderate	10 (3/7)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#B1CFE5	1.14886010100778	1
Repaglinide	Josamycin	0.075	3.589	None	5 (4/1)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#F6B6B6	0.57443005050389	1
Morphine	Rifampicin	0.313	-2.229	Moderate	6 (2/4)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#B1CFE5	0.689316060604668	1
Carbamazepine	Verapamil	0.166	2.243	Major	7 (5/2)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#F7B9B9	0.804202070705446	1
Erythromycin	Warfarin	0.077	-1.114	Major	10 (5/5)	The serum concentration of Warfarin can be increased when it is combined with Erythromycin.	#B4D1E6	1.14886010100778	1
Fluconazole	Ergotamine	0.25	2.019	Moderate	13 (9/4)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#F8BABA	1.49351813131011	1
Diltiazem	Carbamazepine	0.231	-1.592	Major	17 (7/10)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#B2D0E5	1.95306217171323	1
Amiodarone	Clarithromycin	0.116	-2.229	Major	51 (17/34)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#B1CFE5	5.85918651513968	1
Indomethacin	Oxprenolol	0.034	Inf	None	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Oxprenolol.	#B32020	0.114886010100778	1
Azithromycin	Warfarin	0.123	-1.639	Moderate	42 (17/25)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#B2D0E5	4.82521242423268	1
Warfarin	Methimazole	0.36	-1.857	Moderate	8 (3/5)	Methimazole may decrease the anticoagulant activities of Warfarin.	#B2D0E5	0.919088080806224	1
Fluconazole	Carbamazepine	0.19	1.154	Moderate	16 (9/7)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F9BCBC	1.83817616161245	1
Estradiol	Ursodeoxycholic acid	0.338	4.486	None	6 (5/1)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#F5B2B2	0.689316060604668	1
Theophylline	Norfloxacin	0.176	2.991	Moderate	13 (10/3)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#F7B7B7	1.49351813131011	1
Paroxetine	Selegiline	0.308	-1.114	Major	6 (3/3)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#B4D1E6	0.689316060604668	1
Theophylline	Carbamazepine	0.111	-2.972	Moderate	11 (3/8)	The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.	#AFCEE4	1.26374611110856	1
Lithium cation	Etoricoxib	0.11	1.097	None	20 (11/9)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#F9BCBC	2.29772020201556	1
Amitriptyline	Donepezil	0.26	2.094	Moderate	10 (7/3)		#F8BABA	1.14886010100778	1
Phenytoin	Trimethoprim	0.207	-3.622	Moderate	17 (4/13)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#AECDE3	1.95306217171323	1
Bisoprolol	Rifampicin	0.18	-4.876	Moderate	43 (8/35)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#ABCBE2	4.94009843433345	1
Naratriptan	Escitalopram	0.441	1.346	Major	5 (3/2)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Escitalopram.	#F9BCBC	0.57443005050389	1
Ergotamine	Ketoconazole	0.139	Inf	Major	2 (2/0)	The serum concentration of Ergotamine can be increased when it is combined with Ketoconazole.	#B32020	0.229772020201556	1
Erythromycin	Carbamazepine	0.174	1.57	Major	11 (7/4)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#F8BABA	1.26374611110856	1
Methylphenidate	Carbamazepine	0.444	2.692	None	4 (3/1)		#F7B7B7	0.459544040403112	1
Phenytoin	Methylprednisolone	0.297	-1.783	Moderate	13 (5/8)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#B2D0E5	1.49351813131011	1
Repaglinide	Nadolol	0.114	-1.393	Moderate	9 (4/5)		#B4D1E6	1.033974090907	1
Fluoxetine	Frovatriptan	0.363	4.486	Major	6 (5/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#F5B2B2	0.689316060604668	1
Lansoprazole	Ketoconazole	0.431	2.243	Moderate	7 (5/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#F7B9B9	0.804202070705446	1
Dihydroergotamine	Nitroglycerin	0.382	1.795	Moderate	12 (8/4)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#F8BABA	1.37863212120934	1
Erythromycin	Theophylline	0.349	1.795	Moderate	6 (4/2)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#F8BABA	0.689316060604668	1
Moxifloxacin	Amiodarone	0.189	-3.591	Major	38 (9/29)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#AECDE3	4.36566838382956	1
Digoxin	Hydroxychloroquine	0.396	1.122	Moderate	9 (5/4)	The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.	#F9BCBC	1.033974090907	1
Atomoxetine	Paroxetine	0.347	Inf	Major	2 (2/0)	The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.	#B32020	0.229772020201556	1
Fluconazole	Flurazepam	0.203	2.692	None	8 (6/2)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#F7B7B7	0.919088080806224	1
Glyburide	Nadolol	0.318	-2.229	Moderate	15 (5/10)	Nadolol may increase the hypoglycemic activities of Glyburide.	#B1CFE5	1.72329015151167	1
Phenytoin	Methotrexate	0.299	1.196	Moderate	7 (4/3)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#F9BCBC	0.804202070705446	1
Atenolol	Piroxicam	0.195	1.346	Moderate	15 (9/6)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#F9BCBC	1.72329015151167	1
Losartan	Rifampicin	0.158	-3.343	Moderate	32 (8/24)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#AECDE3	3.6763523232249	1
Indomethacin	Lithium cation	0.164	1.047	Major	13 (7/6)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#F9BCBC	1.49351813131011	1
Fluvoxamine	Ergotamine	0.163	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluvoxamine.	#B32020	0.344658030302334	1
Fluconazole	Imipramine	0.121	2.243	Moderate	7 (5/2)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#F7B9B9	0.804202070705446	1
Telithromycin	Atorvastatin	0.091	-1.114	Major	8 (4/4)	The risk or severity of adverse effects can be increased when Telithromycin is combined with Atorvastatin.	#B4D1E6	0.919088080806224	1
Phenytoin	Flurazepam	0.346	-1.114	Moderate	4 (2/2)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#B4D1E6	0.459544040403112	1
Sucralfate	Norfloxacin	0.338	2.243	Moderate	21 (15/6)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#F7B9B9	2.41260621211634	1
Sotalol	Gliclazide	0.177	-2.786	None	14 (4/10)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	1.60840414141089	1
Ciprofloxacin	Tizanidine	0.222	-1.672	Major	55 (22/33)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#B2D0E5	6.31873055554279	1
Ticlopidine	Carbamazepine	0.478	-4.458	Moderate	5 (1/4)	The metabolism of Ticlopidine can be increased when combined with Carbamazepine.	#ABCBE2	0.57443005050389	1
Telmisartan	Lithium cation	0.234	1.077	Moderate	11 (6/5)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#F9BCBC	1.26374611110856	1
Nortriptyline	Rifampicin	0.111	Inf	Minor	1 (1/0)	The metabolism of Nortriptyline can be increased when combined with Rifampicin.	#B32020	0.114886010100778	1
Bumetanide	Ibuprofen	0.142	1.795	Moderate	12 (8/4)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#F8BABA	1.37863212120934	1
Piroxicam	Carvedilol	0.184	-1.672	Moderate	10 (4/6)	Piroxicam may decrease the antihypertensive activities of Carvedilol.	#B2D0E5	1.14886010100778	1
Estradiol	Prednisolone	0.032	Inf	Moderate	1 (1/0)	The serum concentration of Prednisolone can be increased when it is combined with Estradiol.	#B32020	0.114886010100778	1
Risperidone	Itraconazole	0.158	1.196	None	14 (8/6)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#F9BCBC	1.60840414141089	1
Midazolam	Clarithromycin	0.151	1.282	Moderate	17 (10/7)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#F9BCBC	1.95306217171323	1
Lovastatin	Niacin	0.375	Inf	Major	1 (1/0)	The risk or severity of rhabdomyolysis can be increased when Niacin is combined with Lovastatin.	#B32020	0.114886010100778	1
Spironolactone	Fosinopril	0.334	-2.972	Major	11 (3/8)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.	#AFCEE4	1.26374611110856	1
Chlorpropamide	Glucosamine	0.111	Inf	None	1 (1/0)		#B32020	0.114886010100778	1
Indomethacin	Acenocoumarol	0.173	-4.012	None	69 (15/54)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#ACCCE3	7.92713469695368	1
Verapamil	Carvedilol	0.321	-2.786	Major	21 (6/15)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#AFCEE4	2.41260621211634	1
Doxycycline	Insulin aspart	0.27	-1.274	Moderate	15 (7/8)		#B4D1E6	1.72329015151167	1
Rifampicin	Acenocoumarol	0.195	-2.508	None	13 (4/9)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#B1CFE5	1.49351813131011	1
Fluconazole	Fluvastatin	0.199	1.495	Moderate	16 (10/6)	The serum concentration of Fluvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	1.83817616161245	1
Lidocaine	Carvedilol	0.111	-1.811	Moderate	21 (8/13)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#B2D0E5	2.41260621211634	1
Dihydroergotamine	Itraconazole	0.184	1.346	Major	10 (6/4)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#F9BCBC	1.14886010100778	1
Sertraline	Cilostazol	0.285	-7.356	Moderate	38 (5/33)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#A3C5DF	4.36566838382956	1
Amitriptyline	Moclobemide	0.781	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#B32020	0.229772020201556	1
Prednisone	Primidone	0.222	1.495	Moderate	8 (5/3)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#F9BCBC	0.919088080806224	1
Doxycycline	Acenocoumarol	0.105	-3.22	None	35 (9/26)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#AFCEE4	4.02101035352723	1
Trazodone	Warfarin	0.409	-1.486	Minor	14 (6/8)	Trazodone may decrease the anticoagulant activities of Warfarin.	#B4D1E6	1.60840414141089	1
Trandolapril	Lithium cation	0.211	-1.114	Moderate	4 (2/2)	The serum concentration of Lithium can be increased when it is combined with Trandolapril.	#B4D1E6	0.459544040403112	1
Tacrolimus	Clarithromycin	0.301	1.705	Major	29 (19/10)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#F8BABA	3.33169429292256	1
Imipramine	Terbutaline	0.086	Inf	Moderate	5 (5/0)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#B32020	0.57443005050389	1
Piroxicam	Propranolol	0.041	2.243	Moderate	7 (5/2)	Piroxicam may decrease the antihypertensive activities of Propranolol.	#F7B9B9	0.804202070705446	1
Disopyramide	Atenolol	0.515	-3.343	Major	4 (1/3)	Disopyramide may increase the bradycardic activities of Atenolol.	#AECDE3	0.459544040403112	1
Tacrolimus	Itraconazole	0.429	1.009	Major	17 (9/8)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#F9BCBC	1.95306217171323	1
Clonidine	Carvedilol	0.331	-2.229	Major	3 (1/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B1CFE5	0.344658030302334	1
Acitretin	Minocycline	0.2	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Minocycline is combined with Acitretin.	#B32020	0.114886010100778	1
Warfarin	Norfloxacin	0.16	-1.003	Major	19 (10/9)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#B4D1E6	2.18283419191478	1
Venlafaxine	Propafenone	0.282	-1.114	Moderate	14 (7/7)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#B4D1E6	1.60840414141089	1
Irbesartan	Lithium cation	0.254	-1.672	Moderate	15 (6/9)	The serum concentration of Lithium can be increased when it is combined with Irbesartan.	#B2D0E5	1.72329015151167	1
Fluoxetine	Josamycin	0.072	7.178	None	9 (8/1)		#F1ABAB	1.033974090907	1
Pioglitazone	Glucosamine	0.207	1.436	None	13 (8/5)		#F9BCBC	1.49351813131011	1
Cyclophosphamide	Acenocoumarol	0.241	-1.114	None	4 (2/2)		#B4D1E6	0.459544040403112	1
Labetalol	Ibuprofen	0.091	-1.393	Moderate	18 (8/10)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#B4D1E6	2.067948181814	1
Cyclosporine	Amiodarone	0.303	-8.359	Moderate	17 (2/15)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#A0C3DD	1.95306217171323	1
Salbutamol	Rasagiline	0.122	-1.672	Moderate	25 (10/15)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#B2D0E5	2.87215025251945	1
Nortriptyline	Rasagiline	0.182	-1.114	Major	2 (1/1)	Rasagiline may increase the serotonergic activities of Nortriptyline.	#B4D1E6	0.229772020201556	1
Carbamazepine	Metronidazole	0.267	-1.486	Moderate	21 (9/12)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#B4D1E6	2.41260621211634	1
Lovastatin	Colchicine	0.25	-4.458	Major	20 (4/16)	The serum concentration of Colchicine can be increased when it is combined with Lovastatin.	#ABCBE2	2.29772020201556	1
Fluvoxamine	Acenocoumarol	0.235	-2.452	None	16 (5/11)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#B1CFE5	1.83817616161245	1
Formoterol	Nadolol	0.213	-1.532	Major	19 (8/11)		#B4D1E6	2.18283419191478	1
Pravastatin	Colchicine	0.221	-12.418	Major	85 (7/78)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#96BBD9	9.76531085856613	1
Rifampicin	Nifedipine	0.174	-3.901	Major	9 (2/7)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#ACCCE3	1.033974090907	1
Epinephrine	Carvedilol	0.064	-1.393	Major	9 (4/5)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B4D1E6	1.033974090907	1
Perphenazine	Levofloxacin	0.18	1.795	Moderate	9 (6/3)		#F8BABA	1.033974090907	1
Valproic acid	Nimodipine	0.318	-1.857	Minor	8 (3/5)		#B2D0E5	0.919088080806224	1
Acetylsalicylic acid	Heparin	0.079	-1.114	Moderate	2 (1/1)	Acetylsalicylic acid may increase the anticoagulant activities of Heparin.	#B4D1E6	0.229772020201556	1
Metoprolol	Repaglinide	0.347	-3.343	Moderate	12 (3/9)		#AECDE3	1.37863212120934	1
Primidone	Acenocoumarol	0.174	-2.229	None	6 (2/4)	The metabolism of Acenocoumarol can be increased when combined with Primidone.	#B1CFE5	0.689316060604668	1
Disulfiram	Isoniazid	0.559	-1.114	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Isoniazid.	#B4D1E6	0.229772020201556	1
Sucralfate	Etidronic acid	0.143	Inf	None	1 (1/0)		#B32020	0.114886010100778	1
Amitriptyline	Clonidine	0.611	Inf	Major	2 (2/0)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B32020	0.229772020201556	1
Imipramine	Ketoconazole	0.083	Inf	Moderate	1 (1/0)	The metabolism of Imipramine can be decreased when combined with Ketoconazole.	#B32020	0.114886010100778	1
Acenocoumarol	Cholestyramine	0.174	-2.415	None	19 (6/13)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	2.18283419191478	1
Minocycline	Acenocoumarol	0.138	-1.56	None	12 (5/7)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	1.37863212120934	1
Fluvoxamine	Zolmitriptan	0.187	1.346	Moderate	5 (3/2)	The metabolism of Zolmitriptan can be decreased when combined with Fluvoxamine.	#F9BCBC	0.57443005050389	1
Hydrocortisone	Cholestyramine	0.276	1.795	Moderate	9 (6/3)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F8BABA	1.033974090907	1
Glipizide	Nadolol	0.64	-1.114	Moderate	2 (1/1)	Nadolol may increase the hypoglycemic activities of Glipizide.	#B4D1E6	0.229772020201556	1
Triamcinolone	Acenocoumarol	0.119	-3.436	None	49 (12/37)		#AECDE3	5.62941449493812	1
Disopyramide	Levofloxacin	0.036	-2.229	Major	3 (1/2)	Levofloxacin may increase the QTc-prolonging activities of Disopyramide.	#B1CFE5	0.344658030302334	1
Gliclazide	Oxprenolol	1	Inf	None	1 (1/0)	Oxprenolol may increase the hypoglycemic activities of Gliclazide.	#B32020	0.114886010100778	1
Raloxifene	Cholestyramine	0.134	Inf	Moderate	7 (7/0)	Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.804202070705446	1
Nortriptyline	Pseudoephedrine	0.041	Inf	None	3 (3/0)	Nortriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.344658030302334	1
Lovastatin	Josamycin	0.046	Inf	None	3 (3/0)	The serum concentration of Lovastatin can be increased when it is combined with Josamycin.	#B32020	0.344658030302334	1
Fluoxetine	Selegiline	0.32	-1.114	Major	4 (2/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Selegiline.	#B4D1E6	0.459544040403112	1
Itraconazole	Phenobarbital	0.095	1.795	Moderate	6 (4/2)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#F8BABA	0.689316060604668	1
Warfarin	Clarithromycin	0.142	-1.114	Major	18 (9/9)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#B4D1E6	2.067948181814	1
Medroxyprogesterone acetate	Acenocoumarol	0.153	1.795	None	3 (2/1)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#F8BABA	0.344658030302334	1
Atenolol	Chlorpropamide	0.032	Inf	Moderate	1 (1/0)	Atenolol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.114886010100778	1
Warfarin	Naproxen	0.13	-1.532	Major	38 (16/22)	Naproxen may increase the anticoagulant activities of Warfarin.	#B4D1E6	4.36566838382956	1
Fluconazole	Phenytoin	0.208	1.795	Moderate	6 (4/2)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#F8BABA	0.689316060604668	1
Metoprolol	Verapamil	0.466	-3.343	Major	8 (2/6)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#AECDE3	0.919088080806224	1
Ethinylestradiol	Itraconazole	0.5	Inf	Moderate	1 (1/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Itraconazole.	#B32020	0.114886010100778	1
Halazepam	Ketoconazole	0.118	Inf	None	1 (1/0)		#B32020	0.114886010100778	1
Phenytoin	Estradiol	0.372	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Estradiol can be decreased when used in combination with Phenytoin.	#B32020	0.229772020201556	1
Fluvoxamine	Eletriptan	0.476	Inf	Major	1 (1/0)	The serum concentration of Eletriptan can be increased when it is combined with Fluvoxamine.	#B32020	0.114886010100778	1
Diazepam	Ketoconazole	0.223	1.615	Moderate	14 (9/5)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#F8BABA	1.60840414141089	1
Ketoconazole	Budesonide	0.181	-1.393	Major	18 (8/10)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#B4D1E6	2.067948181814	1
Amitriptyline	Cimetidine	0.143	Inf	Moderate	2 (2/0)	The metabolism of Amitriptyline can be decreased when combined with Cimetidine.	#B32020	0.229772020201556	1
Metoprolol	Salmeterol	0.227	-2.229	Moderate	15 (5/10)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#B1CFE5	1.72329015151167	1
Cyclosporine	Clarithromycin	0.161	-1.114	Major	12 (6/6)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#B4D1E6	1.37863212120934	1
Trospium	Clomipramine	0.479	-1.672	Moderate	5 (2/3)		#B2D0E5	0.57443005050389	1
Erythromycin	Quetiapine	0.165	1.795	Major	12 (8/4)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#F8BABA	1.37863212120934	1
Trazodone	Ketoconazole	0.147	Inf	Moderate	3 (3/0)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#B32020	0.344658030302334	1
Midazolam	Ketoconazole	0.021	Inf	Major	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Ketoconazole.	#B32020	0.114886010100778	1
Metronidazole	Phenobarbital	0.05	1.122	Moderate	9 (5/4)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#F9BCBC	1.033974090907	1
Cyclosporine	Glyburide	0.098	-2.972	Moderate	11 (3/8)	The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.	#AFCEE4	1.26374611110856	1
Doxycycline	Iron	0.194	5.384	Moderate	7 (6/1)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F4B1B1	0.804202070705446	1
Carbamazepine	Itraconazole	0.171	-1.114	Moderate	12 (6/6)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#B4D1E6	1.37863212120934	1
Methylprednisolone	Itraconazole	0.471	1.282	Major	17 (10/7)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#F9BCBC	1.95306217171323	1
Rifampicin	Gliclazide	0.162	-2.508	None	13 (4/9)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#B1CFE5	1.49351813131011	1
Warfarin	Cholestyramine	0.191	-1.672	Moderate	5 (2/3)	Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	0.57443005050389	1
Citalopram	Clozapine	0.145	Inf	Major	2 (2/0)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#B32020	0.229772020201556	1
Itraconazole	Acenocoumarol	0.108	-1.824	None	29 (11/18)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#B2D0E5	3.33169429292256	1
Trospium	Ipratropium	0.141	-1.337	Moderate	11 (5/6)	The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Trospium.	#B4D1E6	1.26374611110856	1
Trospium	Glycopyrronium	0.119	-1.114	Moderate	2 (1/1)	Trospium may increase the anticholinergic activities of Glycopyrronium.	#B4D1E6	0.229772020201556	1
Cyclosporine	Diclofenac	0.158	-2.33	Moderate	34 (11/23)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	3.90612434342645	1
Methotrexate	Cholestyramine	0.189	-1.114	None	8 (4/4)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.919088080806224	1
Rivastigmine	Clomipramine	0.239	-2.229	Moderate	6 (2/4)		#B1CFE5	0.689316060604668	1
Moxifloxacin	Iron	0.242	2.243	Moderate	14 (10/4)		#F7B9B9	1.60840414141089	1
Carbamazepine	Norethisterone	0.138	Inf	Major	2 (2/0)	The metabolism of Norethisterone can be increased when combined with Carbamazepine.	#B32020	0.229772020201556	1
Digoxin	Cholestyramine	0.246	-1.486	Moderate	7 (3/4)	Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.804202070705446	1
Dihydroergotamine	Clarithromycin	0.227	2.243	Major	14 (10/4)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#F7B9B9	1.60840414141089	1
Tetracycline	Amoxicillin	0.599	1.602	Moderate	39 (25/14)		#F8BABA	4.48055439393034	1
Glipizide	Carvedilol	0.3	-8.916	Moderate	18 (2/16)	Carvedilol may increase the hypoglycemic activities of Glipizide.	#9FC1DD	2.067948181814	1
Thiethylperazine	Bromocriptine	0.053	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Cyclosporine	Phenytoin	0.214	-2.229	Moderate	3 (1/2)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#B1CFE5	0.344658030302334	1
Phenytoin	Clarithromycin	0.085	-1.751	Moderate	18 (7/11)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#B2D0E5	2.067948181814	1
Cyclosporine	Methylphenidate	0.08	Inf	Minor	1 (1/0)		#B32020	0.114886010100778	1
Ketoconazole	Rabeprazole	0.297	-1.114	Moderate	6 (3/3)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#B4D1E6	0.689316060604668	1
Triazolam	Clarithromycin	0.027	Inf	Moderate	3 (3/0)	The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.	#B32020	0.344658030302334	1
Warfarin	Pentoxifylline	0.289	-8.173	Moderate	25 (3/22)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#A2C4DE	2.87215025251945	1
Venlafaxine	Frovatriptan	0.122	2.692	Major	4 (3/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#F7B7B7	0.459544040403112	1
Pyridostigmine	Methylprednisolone	0.146	1.795	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Pyridostigmine.	#F8BABA	0.344658030302334	1
Bisoprolol	Chlorpropamide	0.583	Inf	Moderate	1 (1/0)	Bisoprolol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.114886010100778	1
Tacrolimus	Felodipine	0.137	1.795	Moderate	3 (2/1)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#F8BABA	0.344658030302334	1
Allopurinol	Mercaptopurine	0.072	-1.114	Major	2 (1/1)	The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.	#B4D1E6	0.229772020201556	1
Lorazepam	Clozapine	0.27	-1.114	Major	6 (3/3)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#B4D1E6	0.689316060604668	1
Donepezil	Oxybutynin	0.51	-1.114	Moderate	2 (1/1)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.	#B4D1E6	0.229772020201556	1
Salbutamol	Doxepin	0.411	3.589	Moderate	5 (4/1)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#F6B6B6	0.57443005050389	1
Metformin	Cimetidine	0.118	-1.486	Moderate	7 (3/4)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#B4D1E6	0.804202070705446	1
Quinapril	Lithium cation	0.377	Inf	Moderate	2 (2/0)	The serum concentration of Lithium can be increased when it is combined with Quinapril.	#B32020	0.229772020201556	1
Phenytoin	Amiodarone	0.518	-3.343	Moderate	8 (2/6)	The serum concentration of Phenytoin can be increased when it is combined with Amiodarone.	#AECDE3	0.919088080806224	1
Rivastigmine	Methotrimeprazine	0.231	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Cyclosporine	Piroxicam	0.048	Inf	Moderate	1 (1/0)	Piroxicam may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.114886010100778	1
Fludrocortisone	Acenocoumarol	0.188	-2.786	None	7 (2/5)		#AFCEE4	0.804202070705446	1
Propranolol	Clonidine	0.216	-2.229	Major	3 (1/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#B1CFE5	0.344658030302334	1
Hydrocortisone	Rifampicin	0.239	1.346	Moderate	5 (3/2)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#F9BCBC	0.57443005050389	1
Fosinopril	Tizanidine	0.215	1.795	Major	3 (2/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Fosinopril.	#F8BABA	0.344658030302334	1
Phenylephrine	Clomipramine	0.111	Inf	Major	1 (1/0)	Clomipramine may increase the vasopressor activities of Phenylephrine.	#B32020	0.114886010100778	1
Cyclosporine	Phenobarbital	0.248	-3.343	Moderate	4 (1/3)	The metabolism of Cyclosporine can be increased when combined with Phenobarbital.	#AECDE3	0.459544040403112	1
Citalopram	Frovatriptan	0.151	1.795	Major	6 (4/2)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#F8BABA	0.689316060604668	1
Amitriptyline	Ketoconazole	0.334	3.589	Moderate	5 (4/1)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#F6B6B6	0.57443005050389	1
Erythromycin	Repaglinide	0.144	-1.672	Moderate	15 (6/9)	The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.	#B2D0E5	1.72329015151167	1
Fluvoxamine	Oxycodone	0.548	-1.672	Moderate	5 (2/3)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxycodone.	#B2D0E5	0.57443005050389	1
Sotalol	Levofloxacin	0.227	-3.343	Major	16 (4/12)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#AECDE3	1.83817616161245	1
Ethinylestradiol	Amoxicillin	0.208	Inf	Moderate	5 (5/0)		#B32020	0.57443005050389	1
Epinephrine	Clomipramine	0.052	2.692	Major	4 (3/1)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#F7B7B7	0.459544040403112	1
Digoxin	Josamycin	0.163	-1.672	None	5 (2/3)	The serum concentration of Digoxin can be increased when it is combined with Josamycin.	#B2D0E5	0.57443005050389	1
Allopurinol	Azathioprine	0.212	-3.622	Major	17 (4/13)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#AECDE3	1.95306217171323	1
Haloperidol	Ketoconazole	0.029	Inf	Major	1 (1/0)	The metabolism of Haloperidol can be decreased when combined with Ketoconazole.	#B32020	0.114886010100778	1
Cyclosporine	Repaglinide	0.315	-7.244	Major	15 (2/13)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#A3C5DF	1.72329015151167	1
Cyclosporine	Clindamycin	0.282	1.346	Moderate	5 (3/2)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#F9BCBC	0.57443005050389	1
Fluvastatin	Colchicine	0.211	-7.058	Major	22 (3/19)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#A5C6DF	2.52749222221712	1
Theophylline	Disulfiram	0.356	-2.229	Moderate	3 (1/2)	The serum concentration of Theophylline can be increased when it is combined with Disulfiram.	#B1CFE5	0.344658030302334	1
Nortriptyline	Epinephrine	0.053	Inf	Major	1 (1/0)	Nortriptyline may decrease the antihypertensive activities of Epinephrine.	#B32020	0.114886010100778	1
Sotalol	Clarithromycin	0.06	1.795	Major	6 (4/2)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#F8BABA	0.689316060604668	1
Fluoxetine	Cilostazol	0.271	-4.737	Moderate	21 (4/17)	The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.	#ABCBE2	2.41260621211634	1
Labetalol	Glyburide	0.339	-5.572	Moderate	6 (1/5)	Labetalol may increase the hypoglycemic activities of Glyburide.	#A8C8E1	0.689316060604668	1
Donepezil	Clomipramine	0.192	-1.114	Moderate	4 (2/2)	The metabolism of Donepezil can be decreased when combined with Clomipramine.	#B4D1E6	0.459544040403112	1
Phenytoin	Itraconazole	0.323	-1.857	Moderate	8 (3/5)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#B2D0E5	0.919088080806224	1
Ranolazine	Verapamil	0.506	-2.229	Major	3 (1/2)	The serum concentration of Ranolazine can be increased when it is combined with Verapamil.	#B1CFE5	0.344658030302334	1
Naratriptan	Sertraline	0.389	1.795	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertraline.	#F8BABA	0.344658030302334	1
Nortriptyline	Terbinafine	0.07	Inf	Moderate	2 (2/0)	The metabolism of Nortriptyline can be decreased when combined with Terbinafine.	#B32020	0.229772020201556	1
Mercaptopurine	Acenocoumarol	0.155	-3.343	None	4 (1/3)	Mercaptopurine may decrease the anticoagulant activities of Acenocoumarol.	#AECDE3	0.459544040403112	1
Ergotamine	Nitroglycerin	0.168	-1.672	Moderate	15 (6/9)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#B2D0E5	1.72329015151167	1
Moxifloxacin	Warfarin	0.101	-2.229	Major	12 (4/8)		#B1CFE5	1.37863212120934	1
Pyridostigmine	Hydrocortisone	0.064	-1.114	Moderate	4 (2/2)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#B4D1E6	0.459544040403112	1
Warfarin	Ofloxacin	0.038	Inf	Major	1 (1/0)		#B32020	0.114886010100778	1
Metoprolol	Indomethacin	0.159	-4.458	Moderate	15 (3/12)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#ABCBE2	1.72329015151167	1
Minocycline	Iron	0.476	1.346	Moderate	5 (3/2)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	0.57443005050389	1
Betamethasone	Acenocoumarol	0.072	-1.337	None	11 (5/6)		#B4D1E6	1.26374611110856	1
Alprazolam	Telithromycin	0.191	Inf	Moderate	3 (3/0)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#B32020	0.344658030302334	1
Fluvoxamine	Rasagiline	0.182	Inf	Major	1 (1/0)	The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.	#B32020	0.114886010100778	1
Warfarin	Rifampicin	0.184	-3.343	Major	4 (1/3)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#AECDE3	0.459544040403112	1
Indomethacin	Labetalol	0.019	Inf	Moderate	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Labetalol.	#B32020	0.114886010100778	1
Erythromycin	Rifampicin	0.417	Inf	Moderate	2 (2/0)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#B32020	0.229772020201556	1
Fluconazole	Pimozide	0.167	Inf	Major	1 (1/0)	The serum concentration of Pimozide can be increased when it is combined with Fluconazole.	#B32020	0.114886010100778	1
Amitriptyline	Phenylephrine	0.667	Inf	Major	2 (2/0)	Amitriptyline may increase the vasopressor activities of Phenylephrine.	#B32020	0.229772020201556	1
Cyclosporine	Oxcarbazepine	0.091	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Carbamazepine	Midazolam	0.224	-3.343	Moderate	8 (2/6)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#AECDE3	0.919088080806224	1
Fentanyl	Ketoconazole	0.378	-2.229	Major	6 (2/4)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#B1CFE5	0.689316060604668	1
Chlorthalidone	Lithium cation	0.286	2.692	Major	4 (3/1)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#F7B7B7	0.459544040403112	1
Disulfiram	Acenocoumarol	0.23	-5.944	None	19 (3/16)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#A8C8E1	2.18283419191478	1
Erythromycin	Colchicine	0.23	-1.857	Major	8 (3/5)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#B2D0E5	0.919088080806224	1
Theophylline	Josamycin	1	Inf	None	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Josamycin.	#B32020	0.114886010100778	1
Cimetidine	Diazepam	0.181	-1.114	Moderate	6 (3/3)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#B4D1E6	0.689316060604668	1
Erythromycin	Lincomycin	0.25	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#B32020	0.114886010100778	1
Diltiazem	Triazolam	0.417	Inf	Moderate	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Diltiazem.	#B32020	0.114886010100778	1
Metoprolol	Piroxicam	0.201	-3.343	Moderate	4 (1/3)	Piroxicam may decrease the antihypertensive activities of Metoprolol.	#AECDE3	0.459544040403112	1
Metoprolol	Terbutaline	0.111	-2.229	Moderate	9 (3/6)	Metoprolol may decrease the bronchodilatory activities of Terbutaline.	#B1CFE5	1.033974090907	1
Itraconazole	Ciclesonide	0.371	1.795	Moderate	3 (2/1)	The metabolism of Ciclesonide can be decreased when combined with Itraconazole.	#F8BABA	0.344658030302334	1
Erythromycin	Amiodarone	0.177	-1.393	Major	9 (4/5)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#B4D1E6	1.033974090907	1
Colestipol	Acenocoumarol	0.183	-2.229	None	6 (2/4)	Colestipol can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	0.689316060604668	1
Doxycycline	Phenobarbital	0.077	-3.343	Moderate	8 (2/6)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#AECDE3	0.919088080806224	1
Eletriptan	Clarithromycin	0.038	Inf	Major	4 (4/0)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#B32020	0.459544040403112	1
Testosterone	Acenocoumarol	0.228	-56.838	None	52 (1/51)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	5.97407252524046	1
Methotrexate	Tetracycline	0.047	2.692	Moderate	4 (3/1)		#F7B7B7	0.459544040403112	1
Cyclosporine	Colchicine	0.124	-10.03	Major	10 (1/9)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#9CBFDB	1.14886010100778	1
Norethisterone	Phenobarbital	0.111	Inf	Major	1 (1/0)	The metabolism of Norethisterone can be increased when combined with Phenobarbital.	#B32020	0.114886010100778	1
Clarithromycin	Colchicine	0.246	-3.025	Major	26 (7/19)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#AFCEE4	2.98703626262023	1
Theophylline	Propafenone	0.034	Inf	Moderate	1 (1/0)	The serum concentration of Theophylline can be increased when it is combined with Propafenone.	#B32020	0.114886010100778	1
Metoprolol	Phenobarbital	0.25	Inf	Moderate	1 (1/0)	The serum concentration of Metoprolol can be decreased when it is combined with Phenobarbital.	#B32020	0.114886010100778	1
Carbamazepine	Warfarin	0.376	-2.786	Moderate	7 (2/5)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#AFCEE4	0.804202070705446	1
Metoprolol	Lidocaine	0.094	-1.114	Moderate	4 (2/2)	The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.	#B4D1E6	0.459544040403112	1
Gliclazide	Nadolol	0.302	-4.179	None	19 (4/15)	Nadolol may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	2.18283419191478	1
Phenytoin	Theophylline	0.036	-1.114	Moderate	2 (1/1)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#B4D1E6	0.229772020201556	1
Digoxin	Minocycline	0.21	1.795	Moderate	3 (2/1)		#F8BABA	0.344658030302334	1
Hydroxyzine	Donepezil	0.083	Inf	Moderate	3 (3/0)		#B32020	0.344658030302334	1
Prednisone	Ketoconazole	0.448	-3.789	Moderate	22 (5/17)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#AECDE3	2.52749222221712	1
Amitriptyline	Rifampicin	0.331	-1.393	Minor	9 (4/5)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#B4D1E6	1.033974090907	1
Felodipine	Itraconazole	0.135	1.795	Major	3 (2/1)	The serum concentration of Felodipine can be increased when it is combined with Itraconazole.	#F8BABA	0.344658030302334	1
Dextromethorphan	Terbinafine	0.431	3.29	Major	14 (11/3)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#F6B6B6	1.60840414141089	1
Theophylline	Propranolol	0.173	-1.486	Major	7 (3/4)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#B4D1E6	0.804202070705446	1
Prednisone	Ethinylestradiol	0.32	Inf	Moderate	2 (2/0)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.229772020201556	1
Conjugated estrogens	Prednisone	0.083	Inf	Moderate	3 (3/0)	The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.	#B32020	0.344658030302334	1
Citalopram	Pimozide	0.148	1.795	Major	3 (2/1)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#F8BABA	0.344658030302334	1
Azithromycin	Disopyramide	0.136	-1.114	Major	2 (1/1)	Azithromycin may increase the QTc-prolonging activities of Disopyramide.	#B4D1E6	0.229772020201556	1
Clarithromycin	Everolimus	0.047	1.795	Major	3 (2/1)	The serum concentration of Everolimus can be increased when it is combined with Clarithromycin.	#F8BABA	0.344658030302334	1
Metoprolol	Diltiazem	0.559	-4.458	Major	10 (2/8)	The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.	#ABCBE2	1.14886010100778	1
Haloperidol	Rifampicin	0.132	-3.343	Major	4 (1/3)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#AECDE3	0.459544040403112	1
Propranolol	Glipizide	0.318	-2.786	Moderate	7 (2/5)	Propranolol may increase the hypoglycemic activities of Glipizide.	#AFCEE4	0.804202070705446	1
Warfarin	Disulfiram	0.207	-5.572	Moderate	6 (1/5)	The serum concentration of Warfarin can be increased when it is combined with Disulfiram.	#A8C8E1	0.689316060604668	1
Disulfiram	Metronidazole	0.208	-2.229	Major	9 (3/6)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#B1CFE5	1.033974090907	1
Methotrexate	Ketoprofen	0.128	Inf	Major	2 (2/0)	The serum concentration of Methotrexate can be increased when it is combined with Ketoprofen.	#B32020	0.229772020201556	1
Sotalol	Ergotamine	0.4	Inf	Moderate	1 (1/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#B32020	0.114886010100778	1
Griseofulvin	Acetylsalicylic acid	0.051	1.795	Minor	3 (2/1)		#F8BABA	0.344658030302334	1
Rifabutin	Atorvastatin	0.045	Inf	Moderate	1 (1/0)	The metabolism of Atorvastatin can be increased when combined with Rifabutin.	#B32020	0.114886010100778	1
Doxycycline	Methotrexate	0.141	-1.393	Moderate	9 (4/5)		#B4D1E6	1.033974090907	1
Cyclosporine	Rosuvastatin	0.248	-3.901	Major	9 (2/7)	The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.	#ACCCE3	1.033974090907	1
Fluvoxamine	Phenytoin	0.121	-2.229	Moderate	3 (1/2)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#B1CFE5	0.344658030302334	1
Sucralfate	Itraconazole	0.385	1.795	None	6 (4/2)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F8BABA	0.689316060604668	1
Midazolam	Josamycin	0.048	Inf	None	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Josamycin.	#B32020	0.114886010100778	1
Terbutaline	Nadolol	0.064	2.692	Major	4 (3/1)		#F7B7B7	0.459544040403112	1
Famotidine	Itraconazole	0.391	-1.114	Moderate	4 (2/2)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#B4D1E6	0.459544040403112	1
Primidone	Dexamethasone	0.031	Inf	Moderate	1 (1/0)	The serum concentration of Dexamethasone can be decreased when it is combined with Primidone.	#B32020	0.114886010100778	1
Fluvoxamine	Imipramine	0.62	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#B32020	0.114886010100778	1
Phenytoin	Tacrolimus	0.272	-2.786	Major	7 (2/5)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#AFCEE4	0.804202070705446	1
Trospium	Amitriptyline	0.126	2.692	Moderate	4 (3/1)		#F7B7B7	0.459544040403112	1
Colestipol	Digoxin	0.244	-3.343	Moderate	4 (1/3)	Colestipol can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#AECDE3	0.459544040403112	1
Prednisolone	Acetylsalicylic acid	0.069	-1.857	Moderate	8 (3/5)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#B2D0E5	0.919088080806224	1
Colestipol	Raloxifene	0.301	Inf	Moderate	2 (2/0)	Colestipol can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.229772020201556	1
Trospium	Cetirizine	0.304	1.795	None	6 (4/2)		#F8BABA	0.689316060604668	1
Fluoxetine	Rasagiline	0.32	-2.786	Major	14 (4/10)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#AFCEE4	1.60840414141089	1
Eletriptan	Ergotamine	0.062	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#B32020	0.114886010100778	1
Haloperidol	Itraconazole	0.282	-1.114	Moderate	6 (3/3)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#B4D1E6	0.689316060604668	1
Fosinopril	Lithium cation	0.228	-2.229	Moderate	3 (1/2)	The serum concentration of Lithium can be increased when it is combined with Fosinopril.	#B1CFE5	0.344658030302334	1
Trospium	Desloratadine	0.39	1.795	None	3 (2/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#F8BABA	0.344658030302334	1
Pantoprazole	Ketoconazole	0.079	-1.114	Moderate	6 (3/3)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#B4D1E6	0.689316060604668	1
Cyclosporine	Indomethacin	0.182	-5.572	Moderate	12 (2/10)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#A8C8E1	1.37863212120934	1
Atenolol	Ampicillin	0.236	-1.672	Moderate	5 (2/3)	The bioavailability of Atenolol can be decreased when combined with Ampicillin.	#B2D0E5	0.57443005050389	1
Galantamine	Solifenacin	0.352	-4.458	Moderate	5 (1/4)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Galantamine.	#ABCBE2	0.57443005050389	1
Phenytoin	Estriol	0.083	Inf	None	2 (2/0)		#B32020	0.229772020201556	1
Celecoxib	Rifampicin	0.103	1.346	Moderate	5 (3/2)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#F9BCBC	0.57443005050389	1
Selegiline	Escitalopram	0.209	-3.343	Major	4 (1/3)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#AECDE3	0.459544040403112	1
Imipramine	Terbinafine	0.087	1.795	Moderate	3 (2/1)	The metabolism of Imipramine can be decreased when combined with Terbinafine.	#F8BABA	0.344658030302334	1
Labetalol	Gliclazide	0.255	-2.229	None	3 (1/2)	Labetalol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	0.344658030302334	1
Labetalol	Salbutamol	0.064	-1.672	Major	5 (2/3)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#B2D0E5	0.57443005050389	1
Fluconazole	Cyclophosphamide	0.583	-2.229	None	3 (1/2)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#B1CFE5	0.344658030302334	1
Lamotrigine	Rifampicin	0.039	Inf	Moderate	1 (1/0)	The metabolism of Lamotrigine can be increased when combined with Rifampicin.	#B32020	0.114886010100778	1
Tramadol	Moclobemide	0.078	Inf	None	2 (2/0)	Tramadol may increase the neuroexcitatory activities of Moclobemide.	#B32020	0.229772020201556	1
Primidone	Methylprednisolone	0.238	-1.114	Moderate	2 (1/1)	The serum concentration of Methylprednisolone can be decreased when it is combined with Primidone.	#B4D1E6	0.229772020201556	1
Fluvoxamine	Warfarin	0.077	Inf	Moderate	1 (1/0)	The metabolism of Warfarin can be decreased when combined with Fluvoxamine.	#B32020	0.114886010100778	1
Ofloxacin	Acenocoumarol	0.074	-3.901	None	9 (2/7)		#ACCCE3	1.033974090907	1
Dextromethorphan	Selegiline	0.136	Inf	Major	1 (1/0)	Selegiline may increase the serotonergic activities of Dextromethorphan.	#B32020	0.114886010100778	1
Fluconazole	Triazolam	0.091	Inf	Major	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Fluconazole.	#B32020	0.114886010100778	1
Phenytoin	Mebendazole	0.031	Inf	Moderate	1 (1/0)	The serum concentration of Mebendazole can be decreased when it is combined with Phenytoin.	#B32020	0.114886010100778	1
Phenobarbital	Estriol	0.029	Inf	None	2 (2/0)		#B32020	0.229772020201556	1
Verapamil	Rifampicin	0.303	-5.572	Moderate	6 (1/5)	The metabolism of Verapamil can be increased when combined with Rifampicin.	#A8C8E1	0.689316060604668	1
Labetalol	Salmeterol	0.264	-1.114	Major	2 (1/1)	Labetalol may decrease the vasoconstricting activities of Salmeterol.	#B4D1E6	0.229772020201556	1
Cyclosporine	Verapamil	0.644	-6.687	Moderate	7 (1/6)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#A5C6DF	0.804202070705446	1
Erythromycin	Tacrolimus	0.148	1.196	Major	7 (4/3)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#F9BCBC	0.804202070705446	1
Warfarin	Minocycline	0.194	-2.229	Moderate	3 (1/2)	Minocycline may increase the anticoagulant activities of Warfarin.	#B1CFE5	0.344658030302334	1
Meloxicam	Lithium cation	0.135	1.346	Major	5 (3/2)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#F9BCBC	0.57443005050389	1
Spironolactone	Cilazapril	0.667	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.	#B32020	0.114886010100778	1
Carbamazepine	Isoniazid	1	Inf	Moderate	1 (1/0)	The metabolism of Carbamazepine can be decreased when combined with Isoniazid.	#B32020	0.114886010100778	1
Metoprolol	Dihydroergotamine	0.081	-1.114	Moderate	2 (1/1)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B4D1E6	0.229772020201556	1
Thiethylperazine	Levofloxacin	0.518	1.346	None	20 (12/8)		#F9BCBC	2.29772020201556	1
Rifampicin	Amiodarone	0.349	-5.572	Major	6 (1/5)	The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.	#A8C8E1	0.689316060604668	1
Prednisolone	Acenocoumarol	0.041	-1.114	None	2 (1/1)		#B4D1E6	0.229772020201556	1
Phenobarbital	Dexamethasone	0.278	-4.458	Moderate	10 (2/8)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#ABCBE2	1.14886010100778	1
Metoclopramide	Levodopa	0.146	-2.898	Moderate	18 (5/13)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#AFCEE4	2.067948181814	1
Theophylline	Acyclovir	0.515	-1.672	Minor	5 (2/3)		#B2D0E5	0.57443005050389	1
Cyclosporine	Carbamazepine	0.482	Inf	Major	1 (1/0)	The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.	#B32020	0.114886010100778	1
Dextromethorphan	Rasagiline	0.236	1.346	Major	5 (3/2)	Rasagiline may increase the serotonergic activities of Dextromethorphan.	#F9BCBC	0.57443005050389	1
Hydrocortisone	Primidone	0.111	Inf	Moderate	1 (1/0)	The serum concentration of Hydrocortisone can be decreased when it is combined with Primidone.	#B32020	0.114886010100778	1
Tizanidine	Rivastigmine	0.167	Inf	Moderate	1 (1/0)	Tizanidine may increase the bradycardic activities of Rivastigmine.	#B32020	0.114886010100778	1
Atenolol	Clonidine	0.506	-2.229	Major	3 (1/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B1CFE5	0.344658030302334	1
Tizanidine	Captopril	0.081	-1.486	Major	7 (3/4)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#B4D1E6	0.804202070705446	1
Salbutamol	Oxprenolol	0.319	Inf	None	1 (1/0)	Oxprenolol may decrease the bronchodilatory activities of Salbutamol.	#B32020	0.114886010100778	1
Lamotrigine	Norethisterone	1	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Simvastatin	Telithromycin	0.081	-1.857	Major	8 (3/5)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#B2D0E5	0.919088080806224	1
Pyridostigmine	Dexamethasone	0.412	-3.343	Moderate	4 (1/3)	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pyridostigmine.	#AECDE3	0.459544040403112	1
Captopril	Lithium cation	0.197	-1.114	Moderate	4 (2/2)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#B4D1E6	0.459544040403112	1
Warfarin	Dexamethasone	0.303	-3.901	Moderate	9 (2/7)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#ACCCE3	1.033974090907	1
Fluvoxamine	Almotriptan	1	Inf	Major	1 (1/0)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#B32020	0.114886010100778	1
Lovastatin	Ketoconazole	0.04	-1.114	Major	2 (1/1)	The serum concentration of Lovastatin can be increased when it is combined with Ketoconazole.	#B4D1E6	0.229772020201556	1
Trospium	Cyclobenzaprine	0.033	Inf	Moderate	2 (2/0)		#B32020	0.229772020201556	1
Doxycycline	Insulin detemir	0.187	-1.114	Moderate	4 (2/2)		#B4D1E6	0.459544040403112	1
Moxifloxacin	Josamycin	0.75	Inf	None	2 (2/0)		#B32020	0.229772020201556	1
Fluorouracil	Acenocoumarol	0.234	-2.229	None	3 (1/2)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluorouracil.	#B1CFE5	0.344658030302334	1
Haloperidol	Glycopyrronium	0.478	-3.343	Moderate	4 (1/3)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#AECDE3	0.459544040403112	1
Ibuprofen	Oxprenolol	0.352	1.795	None	3 (2/1)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#F8BABA	0.344658030302334	1
Betamethasone	Phenobarbital	0.23	-2.229	Moderate	3 (1/2)	The serum concentration of Betamethasone can be decreased when it is combined with Phenobarbital.	#B1CFE5	0.344658030302334	1
Clonidine	Bisoprolol	0.267	-5.572	Major	6 (1/5)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#A8C8E1	0.689316060604668	1
Tetracycline	Iron	0.302	1.795	Moderate	3 (2/1)		#F8BABA	0.344658030302334	1
Clozapine	Ciprofloxacin	0.24	-2.229	Major	3 (1/2)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#B1CFE5	0.344658030302334	1
Cyclobenzaprine	Rivastigmine	0.167	-1.114	Moderate	4 (2/2)		#B4D1E6	0.459544040403112	1
Enalapril	Drospirenone	0.022	-1.114	Moderate	2 (1/1)	Enalapril may increase the hyperkalemic activities of Drospirenone.	#B4D1E6	0.229772020201556	1
Phenoxymethylpenicillin	Methotrexate	0.068	-1.114	Major	4 (2/2)	The serum concentration of Methotrexate can be increased when it is combined with Phenoxymethylpenicillin.	#B4D1E6	0.459544040403112	1
Glimepiride	Rifampicin	0.085	-3.343	Moderate	4 (1/3)	The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.	#AECDE3	0.459544040403112	1
Tizanidine	Donepezil	0.48	-1.114	Moderate	2 (1/1)	Tizanidine may increase the bradycardic activities of Donepezil.	#B4D1E6	0.229772020201556	1
Paroxetine	Moclobemide	0.58	-1.114	None	2 (1/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#B4D1E6	0.229772020201556	1
Fluvastatin	Bezafibrate	0.273	-7.801	None	8 (1/7)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#A2C4DE	0.919088080806224	1
Flurbiprofen	Acenocoumarol	0.163	-1.114	None	2 (1/1)	Flurbiprofen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.229772020201556	1
Ergotamine	Josamycin	0.5	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Josamycin.	#B32020	0.114886010100778	1
Verapamil	Nadolol	0.071	-2.229	Major	3 (1/2)	Verapamil may increase the hypotensive activities of Nadolol.	#B1CFE5	0.344658030302334	1
Fluconazole	Ranolazine	0.31	-1.114	Major	2 (1/1)	The serum concentration of Ranolazine can be increased when it is combined with Fluconazole.	#B4D1E6	0.229772020201556	1
Ranitidine	Ketoconazole	0.125	1.795	Moderate	3 (2/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#F8BABA	0.344658030302334	1
Piroxicam	Acenocoumarol	0.352	-1.672	None	5 (2/3)	Piroxicam may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	0.57443005050389	1
Erythromycin	Dihydroergotamine	0.187	1.795	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#F8BABA	0.344658030302334	1
Carbamazepine	Josamycin	0.048	-1.114	None	2 (1/1)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#B4D1E6	0.229772020201556	1
Fluvoxamine	Sumatriptan	0.115	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.	#B32020	0.114886010100778	1
Dextromethorphan	Memantine	0.289	-2.229	Minor	6 (2/4)	The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Memantine.	#B1CFE5	0.689316060604668	1
Moxifloxacin	Sucralfate	0.41	-1.114	Moderate	6 (3/3)		#B4D1E6	0.689316060604668	1
Fluconazole	Warfarin	0.113	-1.114	Major	4 (2/2)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#B4D1E6	0.459544040403112	1
Nabumetone	Warfarin	0.195	-5.572	Major	6 (1/5)	Nabumetone may increase the anticoagulant activities of Warfarin.	#A8C8E1	0.689316060604668	1
Cyclosporine	Lovastatin	0.368	-4.458	Major	5 (1/4)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#ABCBE2	0.57443005050389	1
Ketoconazole	Quetiapine	0.101	-1.114	Major	2 (1/1)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#B4D1E6	0.229772020201556	1
Erythromycin	Felodipine	0.065	-1.114	Moderate	2 (1/1)	The metabolism of Felodipine can be decreased when combined with Erythromycin.	#B4D1E6	0.229772020201556	1
Repaglinide	Rifampicin	0.128	-6.687	Moderate	7 (1/6)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#A5C6DF	0.804202070705446	1
Propranolol	Epinephrine	0.519	-1.114	Major	4 (2/2)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#B4D1E6	0.459544040403112	1
Trifluoperazine	Levofloxacin	0.1	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Moxifloxacin	Ziprasidone	0.037	Inf	Major	1 (1/0)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#B32020	0.114886010100778	1
Trospium	Tiotropium	0.323	-3.343	Moderate	4 (1/3)	Trospium may increase the anticholinergic activities of Tiotropium.	#AECDE3	0.459544040403112	1
Alfuzosin	Itraconazole	0.155	-16.717	Major	16 (1/15)	The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.	#89B1D3	1.83817616161245	1
Alendronic acid	Mefenamic acid	0.032	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Alendronic acid.	#B32020	0.114886010100778	1
Nifedipine	Phenobarbital	0.693	-5.572	Major	6 (1/5)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#A8C8E1	0.689316060604668	1
Phenytoin	Doxycycline	0.058	-3.343	Moderate	4 (1/3)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#AECDE3	0.459544040403112	1
Warfarin	Hydrocortisone	0.185	-2.786	Moderate	7 (2/5)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#AFCEE4	0.804202070705446	1
Terbinafine	Acenocoumarol	0.099	-7.244	None	30 (4/26)		#A3C5DF	3.44658030302334	1
Eletriptan	Itraconazole	0.02	Inf	Major	1 (1/0)	The serum concentration of Eletriptan can be increased when it is combined with Itraconazole.	#B32020	0.114886010100778	1
Trandolapril	Tizanidine	0.045	-1.114	Major	2 (1/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Trandolapril.	#B4D1E6	0.229772020201556	1
Cyclosporine	Terbinafine	0.076	-3.343	Minor	4 (1/3)	The metabolism of Cyclosporine can be decreased when combined with Terbinafine.	#AECDE3	0.459544040403112	1
Indomethacin	Sotalol	0.525	-1.114	Moderate	2 (1/1)	Indomethacin may decrease the antihypertensive activities of Sotalol.	#B4D1E6	0.229772020201556	1
Salbutamol	Moclobemide	0.053	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Moclobemide is combined with Salbutamol.	#B32020	0.114886010100778	1
Colestipol	Hydrocortisone	0.143	Inf	Moderate	1 (1/0)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.114886010100778	1
Warfarin	Cloxacillin	0.102	-7.801	Moderate	16 (2/14)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#A2C4DE	1.83817616161245	1
Sotalol	Terbutaline	0.474	-2.229	Major	3 (1/2)	Terbutaline may increase the QTc-prolonging activities of Sotalol.	#B1CFE5	0.344658030302334	1
Cyclobenzaprine	Rasagiline	0.1	-1.672	Major	5 (2/3)	Cyclobenzaprine may increase the serotonergic activities of Rasagiline.	#B2D0E5	0.57443005050389	1
Warfarin	Metronidazole	0.245	-3.343	Major	8 (2/6)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#AECDE3	0.919088080806224	1
Theophylline	Pentoxifylline	0.272	-8.916	Moderate	9 (1/8)	The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.	#9FC1DD	1.033974090907	1
Fluconazole	Dihydroergotamine	0.408	1.795	Moderate	3 (2/1)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#F8BABA	0.344658030302334	1
Salmeterol	Nadolol	0.33	-10.588	Major	21 (2/19)		#9ABEDB	2.41260621211634	1
Doxycycline	Warfarin	0.072	-1.114	Moderate	2 (1/1)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#B4D1E6	0.229772020201556	1
Triamcinolone	Rifampicin	0.083	-1.114	Moderate	2 (1/1)	The metabolism of Triamcinolone can be increased when combined with Rifampicin.	#B4D1E6	0.229772020201556	1
Fluvoxamine	Tizanidine	0.279	-1.114	Major	2 (1/1)	The serum concentration of Tizanidine can be increased when it is combined with Fluvoxamine.	#B4D1E6	0.229772020201556	1
Lidocaine	Nadolol	0.084	-1.114	Moderate	2 (1/1)	The serum concentration of Lidocaine can be increased when it is combined with Nadolol.	#B4D1E6	0.229772020201556	1
Fluconazole	Nortriptyline	0.163	-2.229	Moderate	3 (1/2)	The metabolism of Nortriptyline can be decreased when combined with Fluconazole.	#B1CFE5	0.344658030302334	1
Fluconazole	Rifampicin	0.395	-5.572	Major	6 (1/5)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#A8C8E1	0.689316060604668	1
Clozapine	Diazepam	0.358	-2.229	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#B1CFE5	0.344658030302334	1
Tizanidine	Quinapril	0.165	-3.343	Major	4 (1/3)	The risk or severity of hypotension can be increased when Tizanidine is combined with Quinapril.	#AECDE3	0.459544040403112	1
Eprosartan	Lithium cation	0.298	-4.458	Moderate	5 (1/4)	The serum concentration of Lithium can be increased when it is combined with Eprosartan.	#ABCBE2	0.57443005050389	1
Alprazolam	Cimetidine	0.108	-6.687	Moderate	7 (1/6)		#A5C6DF	0.804202070705446	1
Doxycycline	Phenoxymethylpenicillin	0.75	-2.229	Moderate	3 (1/2)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Doxycycline.	#B1CFE5	0.344658030302334	1
Erythromycin	Midazolam	0.036	Inf	Moderate	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Erythromycin.	#B32020	0.114886010100778	1
Esomeprazole	Ketoconazole	0.205	-1.114	Moderate	2 (1/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#B4D1E6	0.229772020201556	1
Codeine	Cimetidine	0.35	-1.114	Moderate	2 (1/1)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#B4D1E6	0.229772020201556	1
Terbutaline	Rasagiline	0.023	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.	#B32020	0.114886010100778	1
Triamcinolone	Phenobarbital	0.095	-2.229	Moderate	3 (1/2)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#B1CFE5	0.344658030302334	1
Chlorpromazine	Levofloxacin	0.422	-2.229	Moderate	3 (1/2)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#B1CFE5	0.344658030302334	1
Midazolam	Itraconazole	0.537	-1.114	Major	2 (1/1)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#B4D1E6	0.229772020201556	1
Tetracycline	Insulin aspart	0.042	-5.572	Moderate	6 (1/5)		#A8C8E1	0.689316060604668	1
Doxycycline	Carbamazepine	0.083	-6.687	Moderate	7 (1/6)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#A5C6DF	0.804202070705446	1
Erythromycin	Itraconazole	0.69	-1.672	Major	5 (2/3)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#B2D0E5	0.57443005050389	1
Ranolazine	Clarithromycin	0.068	-3.343	Major	4 (1/3)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#AECDE3	0.459544040403112	1
Doxycycline	Digoxin	0.132	-4.458	Moderate	5 (1/4)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#ABCBE2	0.57443005050389	1
Warfarin	Gemfibrozil	0.246	-26.747	Major	25 (1/24)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#6E9DC7	2.87215025251945	1
Codeine	Naltrexone	0.091	-4.458	Major	5 (1/4)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#ABCBE2	0.57443005050389	1
Donepezil	Cyclobenzaprine	0.091	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Minocycline	Cloxacillin	0.396	-3.343	Moderate	4 (1/3)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#AECDE3	0.459544040403112	1
Erythromycin	Ergotamine	0.102	-4.458	Major	5 (1/4)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Erythromycin.	#ABCBE2	0.57443005050389	1
Tetracycline	Cloxacillin	1	Inf	Moderate	1 (1/0)		#B32020	0.114886010100778	1
Digoxin	Itraconazole	0.208	-2.229	Major	3 (1/2)	The serum concentration of Digoxin can be increased when it is combined with Itraconazole.	#B1CFE5	0.344658030302334	1
Warfarin	Etoricoxib	0.28	-2.229	None	3 (1/2)	Etoricoxib may increase the anticoagulant activities of Warfarin.	#B1CFE5	0.344658030302334	1
Celecoxib	Warfarin	0.11	-3.343	Moderate	4 (1/3)	Celecoxib may increase the anticoagulant activities of Warfarin.	#AECDE3	0.459544040403112	1
Trospium	Flavoxate	0.197	-Inf	Moderate	2 (0/2)		#1E61A5	0.229772020201556	0.260074118141337
Disopyramide	Labetalol	0.034	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Labetalol.	#1E61A5	0.114886010100778	1
Pyridostigmine	Fludrocortisone	0.46	-Inf	Moderate	4 (0/4)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#1E61A5	0.459544040403112	0.037544604117381
Erythromycin	Methylergometrine	1	-Inf	None	2 (0/2)	The risk or severity of adverse effects can be increased when Methylergometrine is combined with Erythromycin.	#1E61A5	0.229772020201556	1
Fluvoxamine	Nortriptyline	0.296	-Inf	Major	4 (0/4)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#1E61A5	0.459544040403112	1
Nortriptyline	Moclobemide	0.1	-Inf	None	1 (0/1)	Moclobemide may increase the serotonergic activities of Nortriptyline.	#1E61A5	0.114886010100778	1
Trospium	Fluphenazine	0.142	-Inf	Moderate	2 (0/2)		#1E61A5	0.229772020201556	1
Ranolazine	Disopyramide	0.167	-Inf	Major	1 (0/1)	Ranolazine may increase the QTc-prolonging activities of Disopyramide.	#1E61A5	0.114886010100778	1
Cyclosporine	Danazol	0.033	-Inf	Moderate	1 (0/1)	Danazol may increase the hepatotoxic activities of Cyclosporine.	#1E61A5	0.114886010100778	1
Cefoxitin	Acenocoumarol	0.024	-Inf	None	1 (0/1)	Cefoxitin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.114886010100778	1
Fluconazole	Vincristine	0.25	-Inf	Moderate	1 (0/1)	The metabolism of Vincristine can be decreased when combined with Fluconazole.	#1E61A5	0.114886010100778	1
Clozapine	Carbamazepine	0.675	-Inf	Major	2 (0/2)	Carbamazepine may increase the myelosuppressive activities of Clozapine.	#1E61A5	0.229772020201556	1
Cyclosporine	Ethinylestradiol	0.1	-Inf	Moderate	1 (0/1)	The metabolism of Ethinyl Estradiol can be decreased when combined with Cyclosporine.	#1E61A5	0.114886010100778	1
Donepezil	Zuclopenthixol	0.177	-Inf	None	2 (0/2)		#1E61A5	0.229772020201556	1
Clozapine	Flurazepam	0.25	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Flurazepam is combined with Clozapine.	#1E61A5	0.114886010100778	1
Ticlopidine	Phenytoin	0.258	-Inf	Moderate	3 (0/3)	The serum concentration of Phenytoin can be increased when it is combined with Ticlopidine.	#1E61A5	0.344658030302334	1
Colestipol	Warfarin	0.233	-Inf	Minor	4 (0/4)	Colestipol can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.459544040403112	1
Donepezil	Methotrimeprazine	0.236	-Inf	Moderate	4 (0/4)	The metabolism of Donepezil can be decreased when combined with Methotrimeprazine.	#1E61A5	0.459544040403112	1
Disopyramide	Propranolol	0.615	-Inf	Major	2 (0/2)	Disopyramide may increase the bradycardic activities of Propranolol.	#1E61A5	0.229772020201556	1
Donepezil	Periciazine	0.709	-Inf	None	1 (0/1)		#1E61A5	0.114886010100778	1
Carbamazepine	Doxepin	0.625	-Inf	Moderate	2 (0/2)	The metabolism of Doxepin can be increased when combined with Carbamazepine.	#1E61A5	0.229772020201556	1
Trospium	Trihexyphenidyl	0.176	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Trospium.	#1E61A5	0.114886010100778	1
Galantamine	Oxybutynin	0.642	-Inf	Moderate	2 (0/2)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Galantamine.	#1E61A5	0.229772020201556	1
Ziprasidone	Galantamine	0.518	-Inf	Moderate	1 (0/1)	Galantamine may increase the QTc-prolonging activities of Ziprasidone.	#1E61A5	0.114886010100778	1
Isoniazid	Acenocoumarol	0.265	-Inf	None	16 (0/16)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#1E61A5	1.83817616161245	1
Lidocaine	Labetalol	0.089	-Inf	Moderate	2 (0/2)	The serum concentration of Lidocaine can be increased when it is combined with Labetalol.	#1E61A5	0.229772020201556	1
Phenytoin	Fludrocortisone	0.425	-Inf	Moderate	2 (0/2)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#1E61A5	0.229772020201556	1
Trihexyphenidyl	Galantamine	0.882	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Galantamine.	#1E61A5	0.114886010100778	1
Galantamine	Clomipramine	0.243	-Inf	Moderate	3 (0/3)	The metabolism of Galantamine can be decreased when combined with Clomipramine.	#1E61A5	0.344658030302334	1
Piroxicam	Labetalol	0.017	-Inf	Moderate	1 (0/1)	Piroxicam may decrease the antihypertensive activities of Labetalol.	#1E61A5	0.114886010100778	1
Doxycycline	Rifabutin	1	-Inf	Moderate	1 (0/1)	The metabolism of Rifabutin can be decreased when combined with Doxycycline.	#1E61A5	0.114886010100778	1
Amikacin	Cefuroxime	0.75	-Inf	Moderate	2 (0/2)		#1E61A5	0.229772020201556	1
Galantamine	Methotrimeprazine	0.037	-Inf	Moderate	2 (0/2)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#1E61A5	0.229772020201556	1
Rifampicin	Doxepin	0.286	-Inf	Minor	1 (0/1)	The metabolism of Doxepin can be increased when combined with Rifampicin.	#1E61A5	0.114886010100778	1
Trospium	Donepezil	0.806	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Trospium can be decreased when used in combination with Donepezil.	#1E61A5	0.114886010100778	1
Alprazolam	Aprepitant	0.136	-Inf	Moderate	1 (0/1)	The serum concentration of Alprazolam can be increased when it is combined with Aprepitant.	#1E61A5	0.114886010100778	1
Eplerenone	Tolevamer	0.413	-Inf	None	6 (0/6)		#1E61A5	0.689316060604668	1
Trospium	Imipramine	0.053	-Inf	Moderate	1 (0/1)		#1E61A5	0.114886010100778	1
Rivastigmine	Oxybutynin	0.248	-Inf	Moderate	2 (0/2)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Rivastigmine.	#1E61A5	0.229772020201556	1
Cyclosporine	Ketoconazole	0.159	-Inf	Major	2 (0/2)	The metabolism of Cyclosporine can be decreased when combined with Ketoconazole.	#1E61A5	0.229772020201556	1
Cyclosporine	Chloroquine	0.167	-Inf	Moderate	1 (0/1)	Chloroquine may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.114886010100778	1
Phenytoin	Capecitabine	0.193	-Inf	Moderate	2 (0/2)	The serum concentration of Phenytoin can be increased when it is combined with Capecitabine.	#1E61A5	0.229772020201556	1
Galantamine	Ketoconazole	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Galantamine can be decreased when combined with Ketoconazole.	#1E61A5	0.114886010100778	1
Trihexyphenidyl	Rivastigmine	0.212	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Rivastigmine.	#1E61A5	0.114886010100778	1
Alfuzosin	Ketoconazole	0.158	-Inf	Major	4 (0/4)	The serum concentration of Alfuzosin can be increased when it is combined with Ketoconazole.	#1E61A5	0.459544040403112	1
Irbesartan	Drospirenone	0.017	-Inf	Moderate	1 (0/1)	Irbesartan may increase the hyperkalemic activities of Drospirenone.	#1E61A5	0.114886010100778	1
Erythromycin	Clozapine	0.024	-Inf	Moderate	1 (0/1)	The metabolism of Clozapine can be decreased when combined with Erythromycin.	#1E61A5	0.114886010100778	1
Ketoconazole	Clonazepam	0.074	-Inf	None	5 (0/5)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#1E61A5	0.57443005050389	1
Dihydroergotamine	Isosorbide dinitrate	0.111	-Inf	Moderate	1 (0/1)	The metabolism of Isosorbide Dinitrate can be decreased when combined with Dihydroergotamine.	#1E61A5	0.114886010100778	1
Amikacin	Furosemide	0.583	-Inf	Major	2 (0/2)	The serum concentration of Amikacin can be increased when it is combined with Furosemide.	#1E61A5	0.229772020201556	1
Metoprolol	Hydralazine	0.381	-Inf	Minor	3 (0/3)	Hydralazine may increase the hypotensive activities of Metoprolol.	#1E61A5	0.344658030302334	1
Erlotinib	Clarithromycin	0.045	-Inf	Moderate	1 (0/1)	The serum concentration of Erlotinib can be increased when it is combined with Clarithromycin.	#1E61A5	0.114886010100778	1
Fluconazole	Cilostazol	0.15	-Inf	Major	10 (0/10)	The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.	#1E61A5	1.14886010100778	1
Sucralfate	Ketoconazole	1	-Inf	Minor	2 (0/2)	Sucralfate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.229772020201556	1
Citalopram	Moclobemide	0.36	-Inf	None	2 (0/2)	The serum concentration of Citalopram can be increased when it is combined with Moclobemide.	#1E61A5	0.229772020201556	1
Fluconazole	Eplerenone	0.138	-Inf	Moderate	10 (0/10)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#1E61A5	1.14886010100778	1
Glyburide	Rifampicin	0.268	-Inf	Moderate	8 (0/8)	The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.	#1E61A5	0.919088080806224	1
Warfarin	Isoniazid	0.15	-Inf	Moderate	3 (0/3)	The metabolism of Warfarin can be decreased when combined with Isoniazid.	#1E61A5	0.344658030302334	1
Lovastatin	Telithromycin	0.042	-Inf	Major	1 (0/1)	The serum concentration of Lovastatin can be increased when it is combined with Telithromycin.	#1E61A5	0.114886010100778	1
Ampicillin	Acenocoumarol	0.042	-Inf	None	4 (0/4)	Ampicillin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.459544040403112	1
Chlorpromazine	Donepezil	0.091	-Inf	Moderate	1 (0/1)	The metabolism of Donepezil can be decreased when combined with Chlorpromazine.	#1E61A5	0.114886010100778	1
Doxycycline	Isotretinoin	0.2	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#1E61A5	0.114886010100778	1
Imipramine	Donepezil	0.04	-Inf	Moderate	1 (0/1)	The metabolism of Donepezil can be decreased when combined with Imipramine.	#1E61A5	0.114886010100778	1
Benazepril	Tizanidine	0.25	-Inf	Major	1 (0/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Benazepril.	#1E61A5	0.114886010100778	1
Metoprolol	Primidone	0.118	-Inf	Moderate	1 (0/1)	The serum concentration of Metoprolol can be decreased when it is combined with Primidone.	#1E61A5	0.114886010100778	1
Flutamide	Acenocoumarol	0.239	-Inf	None	2 (0/2)		#1E61A5	0.229772020201556	1
Phenytoin	Sucralfate	0.318	-Inf	Moderate	3 (0/3)		#1E61A5	0.344658030302334	1
Fluphenazine	Levofloxacin	0.157	-Inf	Moderate	6 (0/6)		#1E61A5	0.689316060604668	1
Ketoconazole	Solifenacin	0.037	-Inf	Major	3 (0/3)	The metabolism of Solifenacin can be decreased when combined with Ketoconazole.	#1E61A5	0.344658030302334	1
Sirolimus	Rifampicin	0.591	-Inf	Major	1 (0/1)	The metabolism of Sirolimus can be increased when combined with Rifampicin.	#1E61A5	0.114886010100778	1
Sotalol	Repaglinide	0.42	-Inf	Moderate	4 (0/4)		#1E61A5	0.459544040403112	1
Methadone	Carbamazepine	0.25	-Inf	Major	1 (0/1)	The metabolism of Methadone can be increased when combined with Carbamazepine.	#1E61A5	0.114886010100778	1
Betamethasone	Primidone	0.038	-Inf	Moderate	1 (0/1)	The serum concentration of Betamethasone can be decreased when it is combined with Primidone.	#1E61A5	0.114886010100778	1
Digoxin	Sulfasalazine	0.525	-Inf	Moderate	3 (0/3)	The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.	#1E61A5	0.344658030302334	1
Prazosin	Bisoprolol	0.295	-Inf	Moderate	3 (0/3)	Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.	#1E61A5	0.344658030302334	1
Theophylline	Rifampicin	0.06	-Inf	Moderate	2 (0/2)	The metabolism of Theophylline can be increased when combined with Rifampicin.	#1E61A5	0.229772020201556	1
Dihydroergotamine	Josamycin	0.125	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Josamycin.	#1E61A5	0.114886010100778	1
Ketoconazole	Acenocoumarol	0.095	-Inf	None	5 (0/5)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#1E61A5	0.57443005050389	1
Labetalol	Formoterol	0.162	-Inf	Major	3 (0/3)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#1E61A5	0.344658030302334	1
Itraconazole	Aripiprazole	0.16	-Inf	Moderate	4 (0/4)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#1E61A5	0.459544040403112	1
Piroxicam	Warfarin	0.067	-Inf	Major	2 (0/2)	Piroxicam may increase the anticoagulant activities of Warfarin.	#1E61A5	0.229772020201556	1
Cilostazol	Itraconazole	0.165	-Inf	Major	7 (0/7)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#1E61A5	0.804202070705446	1
Clozapine	Norfloxacin	0.021	-Inf	Major	1 (0/1)	Norfloxacin may increase the QTc-prolonging activities of Clozapine.	#1E61A5	0.114886010100778	1
Phenytoin	Fluorouracil	0.041	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Fluorouracil.	#1E61A5	0.114886010100778	1
Clozapine	Alprazolam	0.478	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#1E61A5	0.229772020201556	1
Rosiglitazone	Ketoconazole	0.111	-Inf	Moderate	1 (0/1)	The metabolism of Rosiglitazone can be decreased when combined with Ketoconazole.	#1E61A5	0.114886010100778	1
Erythromycin	Eplerenone	0.06	-Inf	Moderate	5 (0/5)	The serum concentration of Eplerenone can be increased when it is combined with Erythromycin.	#1E61A5	0.57443005050389	1
Clozapine	Fluoxetine	0.222	-Inf	Moderate	1 (0/1)	The serum concentration of Clozapine can be increased when it is combined with Fluoxetine.	#1E61A5	0.114886010100778	1
Hydroxyzine	Rivastigmine	0.17	-Inf	Moderate	3 (0/3)		#1E61A5	0.344658030302334	1
Cyclosporine	Ketoprofen	0.214	-Inf	Moderate	1 (0/1)	Ketoprofen may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.114886010100778	1
Phenytoin	Betamethasone	0.095	-Inf	Moderate	2 (0/2)	The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.	#1E61A5	0.229772020201556	1
Nortriptyline	Terbutaline	0.191	-Inf	Moderate	2 (0/2)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.	#1E61A5	0.229772020201556	1
Sertraline	Moclobemide	0.2	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Sertraline is combined with Moclobemide.	#1E61A5	0.114886010100778	1
Rifampicin	Fluvastatin	0.183	-Inf	Moderate	3 (0/3)	The metabolism of Fluvastatin can be increased when combined with Rifampicin.	#1E61A5	0.344658030302334	1
Rifampicin	Dexamethasone	0.267	-Inf	Moderate	4 (0/4)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#1E61A5	0.459544040403112	1
Sulindac	Furosemide	1	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulindac.	#1E61A5	0.114886010100778	1
Ranolazine	Sotalol	0.769	-Inf	Major	1 (0/1)	Ranolazine may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.114886010100778	1
Piroxicam	Nadolol	0.333	-Inf	Moderate	1 (0/1)	Piroxicam may decrease the antihypertensive activities of Nadolol.	#1E61A5	0.114886010100778	1
Phenoxymethylpenicillin	Tetracycline	1	-Inf	None	1 (0/1)		#1E61A5	0.114886010100778	1
Warfarin	Primidone	0.034	-Inf	Major	1 (0/1)	The metabolism of Warfarin can be increased when combined with Primidone.	#1E61A5	0.114886010100778	1
Tobramycin	Cefuroxime	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.114886010100778	1
Tacrolimus	Rifampicin	0.236	-Inf	Major	3 (0/3)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#1E61A5	0.344658030302334	1
Hydroxyzine	Galantamine	0.052	-Inf	Moderate	2 (0/2)		#1E61A5	0.229772020201556	1
Eplerenone	Lithium cation	0.354	-Inf	Moderate	3 (0/3)	The serum concentration of Lithium can be increased when it is combined with Eplerenone.	#1E61A5	0.344658030302334	1
Cyclosporine	Sulfasalazine	0.4	-Inf	Major	1 (0/1)	Sulfasalazine may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.114886010100778	1
Prazosin	Carvedilol	0.133	-Inf	Moderate	1 (0/1)	Prazosin may increase the antihypertensive activities of Carvedilol.	#1E61A5	0.114886010100778	1
Verapamil	Primidone	0.028	-Inf	Moderate	1 (0/1)	The metabolism of Verapamil can be increased when combined with Primidone.	#1E61A5	0.114886010100778	1
Bisoprolol	Isoprenaline	0.026	-Inf	Moderate	1 (0/1)	Bisoprolol may decrease the bronchodilatory activities of Isoprenaline.	#1E61A5	0.114886010100778	1
Phenytoin	Disulfiram	0.317	-Inf	Moderate	2 (0/2)	The serum concentration of Phenytoin can be increased when it is combined with Disulfiram.	#1E61A5	0.229772020201556	1
Theophylline	Sotalol	0.5	-Inf	Major	1 (0/1)	Sotalol may decrease the bronchodilatory activities of Theophylline.	#1E61A5	0.114886010100778	1
Testosterone	Warfarin	0.156	-Inf	Major	3 (0/3)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.344658030302334	1
Cyclosporine	Propafenone	1	-Inf	Minor	1 (0/1)	The serum concentration of Propafenone can be increased when it is combined with Cyclosporine.	#1E61A5	0.114886010100778	1
Midazolam	Rifampicin	0.083	-Inf	Minor	1 (0/1)	The metabolism of Midazolam can be increased when combined with Rifampicin.	#1E61A5	0.114886010100778	1
Cyclosporine	Nabumetone	0.333	-Inf	Moderate	1 (0/1)	Nabumetone may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.114886010100778	1
Rosiglitazone	Rifampicin	0.071	-Inf	Moderate	1 (0/1)	The metabolism of Rosiglitazone can be increased when combined with Rifampicin.	#1E61A5	0.114886010100778	1
Erythromycin	Cabergoline	0.026	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#1E61A5	0.114886010100778	1
Griseofulvin	Acenocoumarol	0.026	-Inf	None	1 (0/1)	The serum concentration of Acenocoumarol can be decreased when it is combined with Griseofulvin.	#1E61A5	0.114886010100778	1
Rifampicin	Propafenone	0.071	-Inf	Moderate	1 (0/1)	The serum concentration of Propafenone can be decreased when it is combined with Rifampicin.	#1E61A5	0.114886010100778	1
Labetalol	Repaglinide	0.2	-Inf	Moderate	1 (0/1)		#1E61A5	0.114886010100778	1
Warfarin	Terbinafine	0.143	-Inf	Moderate	3 (0/3)		#1E61A5	0.344658030302334	1
Tetracycline	Quinapril	0.023	-Inf	Moderate	1 (0/1)		#1E61A5	0.114886010100778	1
Cyclosporine	Rifampicin	0.05	-Inf	Major	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Rifampicin.	#1E61A5	0.114886010100778	1
Carbamazepine	Ketoconazole	0.467	-Inf	Moderate	1 (0/1)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#1E61A5	0.114886010100778	1
Eplerenone	Itraconazole	0.271	-Inf	Major	4 (0/4)	The serum concentration of Eplerenone can be increased when it is combined with Itraconazole.	#1E61A5	0.459544040403112	1
Metoprolol	Rifampicin	0.038	-Inf	Moderate	1 (0/1)	The metabolism of Metoprolol can be increased when combined with Rifampicin.	#1E61A5	0.114886010100778	1
Morphine	Naltrexone	0.143	-Inf	Major	1 (0/1)	The therapeutic efficacy of Morphine can be decreased when used in combination with Naltrexone.	#1E61A5	0.114886010100778	1
Ranolazine	Itraconazole	0.119	-Inf	Major	2 (0/2)	The serum concentration of Ranolazine can be increased when it is combined with Itraconazole.	#1E61A5	0.229772020201556	1
Phenytoin	Isoniazid	0.062	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Isoniazid.	#1E61A5	0.114886010100778	1
Clozapine	Lisinopril	0.235	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lisinopril.	#1E61A5	0.114886010100778	1
Doxycycline	Acitretin	0.062	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Acitretin.	#1E61A5	0.114886010100778	1
Glycopyrronium	Rivastigmine	0.477	-Inf	None	1 (0/1)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.	#1E61A5	0.114886010100778	1
Ketoconazole	Cilostazol	0.143	-Inf	Major	1 (0/1)	The serum concentration of Cilostazol can be increased when it is combined with Ketoconazole.	#1E61A5	0.114886010100778	1
Tetracycline	Acenocoumarol	0.067	-Inf	None	3 (0/3)		#1E61A5	0.344658030302334	1
Phenytoin	Rifampicin	0.061	-Inf	Major	1 (0/1)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#1E61A5	0.114886010100778	1
Donepezil	Glycopyrronium	0.75	-Inf	None	1 (0/1)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.	#1E61A5	0.114886010100778	1
Pseudoephedrine	Rasagiline	0.198	-Inf	Moderate	2 (0/2)	Rasagiline may increase the hypertensive activities of Pseudoephedrine.	#1E61A5	0.229772020201556	1
Phenytoin	Triamcinolone	0.03	-Inf	Moderate	2 (0/2)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#1E61A5	0.229772020201556	1
Propranolol	Rifampicin	0.049	-Inf	Moderate	2 (0/2)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#1E61A5	0.229772020201556	1
Pimozide	Clarithromycin	0.025	-Inf	Major	1 (0/1)	The risk or severity of ventricular arrhythmias can be increased when Clarithromycin is combined with Pimozide.	#1E61A5	0.114886010100778	1
Erythromycin	Sotalol	0.024	-Inf	Major	1 (0/1)	Erythromycin may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.114886010100778	1
Theophylline	Lithium cation	0.053	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be decreased when it is combined with Theophylline.	#1E61A5	0.114886010100778	1
Citalopram	Selegiline	0.333	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Selegiline.	#1E61A5	0.114886010100778	1
Ketoprofen	Acenocoumarol	0.058	-Inf	None	2 (0/2)	Ketoprofen may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.229772020201556	1
Diltiazem	Sirolimus	0.333	-Inf	Moderate	1 (0/1)	The metabolism of Sirolimus can be decreased when combined with Diltiazem.	#1E61A5	0.114886010100778	1
Cyclosporine	Bupropion	0.059	-Inf	Moderate	1 (0/1)	The metabolism of Bupropion can be decreased when combined with Cyclosporine.	#1E61A5	0.114886010100778	1
Fluorouracil	Metronidazole	1	-Inf	Moderate	1 (0/1)	The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.	#1E61A5	0.114886010100778	1
Rifampicin	Bupropion	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Bupropion can be increased when combined with Rifampicin.	#1E61A5	0.114886010100778	1
Erythromycin	Cilostazol	0.136	-Inf	Major	2 (0/2)	The serum concentration of Cilostazol can be increased when it is combined with Erythromycin.	#1E61A5	0.229772020201556	1
Tetracycline	Insulin detemir	0.067	-Inf	Moderate	1 (0/1)		#1E61A5	0.114886010100778	1
Erythromycin	Ranolazine	0.019	-Inf	Major	1 (0/1)	The serum concentration of Ranolazine can be increased when it is combined with Erythromycin.	#1E61A5	0.114886010100778	1
Cyclosporine	Erythromycin	0.2	-Inf	Major	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Erythromycin.	#1E61A5	0.114886010100778	1
Ceftriaxone	Acenocoumarol	0.07	-Inf	None	1 (0/1)	Ceftriaxone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.114886010100778	1
Glimepiride	Ketoconazole	0.071	-Inf	None	1 (0/1)	The metabolism of Glimepiride can be decreased when combined with Ketoconazole.	#1E61A5	0.114886010100778	1
Perindopril	Lithium cation	0.071	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Perindopril.	#1E61A5	0.114886010100778	1
Dihydroergotamine	Isosorbide mononitrate	0.333	-Inf	Moderate	1 (0/1)	The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.	#1E61A5	0.114886010100778	1
Lovastatin	Rifampicin	0.167	-Inf	Major	1 (0/1)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#1E61A5	0.114886010100778	1
Doxycycline	Insulin glulisine	0.143	-Inf	Moderate	1 (0/1)		#1E61A5	0.114886010100778	1
Ranolazine	Digoxin	0.1	-Inf	Moderate	1 (0/1)	The serum concentration of Digoxin can be increased when it is combined with Ranolazine.	#1E61A5	0.114886010100778	1
Ergotamine	Isosorbide mononitrate	0.154	-Inf	Moderate	1 (0/1)		#1E61A5	0.114886010100778	1
Tenoxicam	Acenocoumarol	0.022	-Inf	None	1 (0/1)	Tenoxicam may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.114886010100778	1
Ofloxacin	Iron	0.333	-Inf	None	1 (0/1)		#1E61A5	0.114886010100778	1
Terbinafine	Rifampicin	0.333	-Inf	Minor	1 (0/1)	The serum concentration of Terbinafine can be decreased when it is combined with Rifampicin.	#1E61A5	0.114886010100778	1
Moxifloxacin	Sotalol	0.019	-Inf	Major	1 (0/1)	Moxifloxacin may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.114886010100778	1
Sirolimus	Clarithromycin	0.077	-Inf	Major	1 (0/1)	The metabolism of Sirolimus can be decreased when combined with Clarithromycin.	#1E61A5	0.114886010100778	1
Cyclosporine	Itraconazole	0.333	-Inf	Major	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Itraconazole.	#1E61A5	0.114886010100778	1
Rifampicin	Itraconazole	0.5	-Inf	Major	1 (0/1)	The serum concentration of Itraconazole can be decreased when it is combined with Rifampicin.	#1E61A5	0.114886010100778	1
Warfarin	Meloxicam	0.071	-Inf	Major	1 (0/1)	Meloxicam may increase the anticoagulant activities of Warfarin.	#1E61A5	0.114886010100778	1
Warfarin	Itraconazole	0.024	-Inf	Moderate	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#1E61A5	0.114886010100778	1
